0001104659-21-066855.txt : 20210514 0001104659-21-066855.hdr.sgml : 20210514 20210514160841 ACCESSION NUMBER: 0001104659-21-066855 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210514 DATE AS OF CHANGE: 20210514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EYENOVIA, INC. CENTRAL INDEX KEY: 0001682639 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 471178401 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38365 FILM NUMBER: 21924621 BUSINESS ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 813-766-9539 MAIL ADDRESS: STREET 1: 295 MADISON AVENUE, STREET 2: SUITE 2400 CITY: NEW YORK STATE: NY ZIP: 10017 10-Q 1 tm2111695d1_10q.htm FORM 10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: March 31, 2021

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________________ to ______________________

COMMISSION FILE NUMBER: 001-38365

EYENOVIA, INC.
(Exact name of Registrant as Specified in Its Charter)

DELAWARE		47-1178401
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

295 Madison Avenue, Suite 2400 NEW YORK, NY		10017
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (917) 289-1117

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.0001 Par Value	EYEN	Nasdaq Capital Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨	Accelerated filer ¨

Non-accelerated filer x	Smaller reporting company x

	Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any news or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x

The number of outstanding shares of the registrant’s common stock was 25,855,599 as of May 12, 2021.

EYENOVIA, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.	2

Condensed Balance Sheets as of March 31, 2021 (Unaudited) and December 31, 2020	2

Unaudited Condensed Statements of Operations for the Three Months Ended March 31, 2021 and 2020	3

Unaudited Condensed Statements of Changes in Stockholders' Equity for the Three Months Ended March 31, 2021 and 2020	4

Unaudited Condensed Statements of Cash Flows for the Three Months Ended March 31, 2021 and 2020	5

Notes to Unaudited Condensed Financial Statements	6

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.	17

Item 3. Quantitative and Qualitative Disclosures About Market Risk.	21

Item 4. Controls and Procedures.	21

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.	22

Item 1A. Risk Factors.	22

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.	22

Item 3. Defaults Upon Senior Securities.	22

Item 4. Mine Safety Disclosures.	22

Item 5. Other Information.	22

Item 6. Exhibits.	23

SIGNATURES	24

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

EYENOVIA, INC.

Condensed Balance Sheets

	March 31,			December 31,
	2021			2020
		(unaudited)
Assets

Current Assets:
Cash and cash equivalents	$	24,907,048		$	28,371,828
Deferred license costs		800,000			1,600,000
License fee and expense reimbursements receivables		908,231			2,966,039
Prepaid expenses and other current assets		1,409,929			453,478

Total Current Assets		28,025,208			33,391,345

Property and equipment, net		707,419			396,380
Security deposit		119,035			119,035

Total Assets	$	28,851,662		$	33,906,760

Liabilities and Stockholders' Equity

Current Liabilities:
Accounts payable	$	1,815,117		$	1,461,665
Accrued compensation		570,732			1,150,672
Accrued expenses and other current liabilities		1,189,092			1,480,692
Deferred rent - current portion		6,857			7,809
Deferred license fee		12,000,000			14,000,000
Notes payable - current portion		783,818			97,539

Total Current Liabilities		16,365,616			18,198,377

Deferred rent - non-current portion		38,634			38,684
Notes payable - non-current portion		307,291			365,814

Total Liabilities		16,711,541			18,602,875

Commitments and contingencies (Note 7)

Stockholders' Equity:
Preferred stock, $0.0001 par value, 6,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively		-			-
Common stock, $0.0001 par value, 90,000,000 shares authorized; 25,623,577 and 24,978,585 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively		2,563			2,498
Additional paid-in capital		94,930,144			92,742,306
Accumulated deficit		(82,792,586	)		(77,440,919	)

Total Stockholders' Equity		12,140,121			15,303,885

Total Liabilities and Stockholders' Equity	$	28,851,662		$	33,906,760

The accompanying notes are an integral part of these condensed financial statements.

EYENOVIA, INC.

Condensed Statements of Operations

(unaudited)

	For the Three Months Ended
	March 31,
	2021			2020
Operating Income
Revenue	$	2,000,000		$	-
Cost of revenue		(800,000	)		-

Gross Profit		1,200,000			-

Operating Expenses:
Research and development		4,247,726			3,634,287
General and administrative		2,300,327			1,836,782

Total Operating Expenses		6,548,053			5,471,069

Loss From Operations		(5,348,053	)		(5,471,069	)

Other Income (Expense):
Interest expense		(5,148	)		(3,681	)
Interest income		1,534			23,840

Net Loss	$	(5,351,667	)	$	(5,450,910	)

Net Loss Per Share
- Basic and Diluted	$	(0.21	)	$	(0.31	)

Weighted Average Number of
Common Shares Outstanding
- Basic and Diluted		25,330,563			17,308,804

The accompanying notes are an integral part of these condensed financial statements.

EYENOVIA, INC.

Condensed Statements of Changes in Stockholders' Equity

(unaudited)

	For the Three Months Ended March 31, 2021
					Additional					Total
	Common Stock				Paid-In		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Equity
Balance - December 31, 2020		24,978,585	$	2,498	$	92,742,306	$	(77,440,919	)	$	15,303,885

Exercise of stock warrants		644,992		65		1,530,925		-			1,530,990

Stock-based compensation		-		-		656,913		-			656,913

Net loss		-		-		-		(5,351,667	)		(5,351,667	)

Balance - March 31, 2021		25,623,577	$	2,563	$	94,930,144	$	(82,792,586	)	$	12,140,121

	For the Three Months Ended March 31, 2020
					Additional					Total
	Common Stock				Paid-In		Accumulated			Stockholders'
	Shares		Amount		Capital		Deficit			Equity
Balance - January 1, 2020		17,100,726	$	1,710	$	69,409,949	$	(57,671,052	)	$	11,740,607

Issuance of common stock and warrants in private placement [1]		2,675,293		267		5,451,475		-			5,451,742


Stock-based compensation		-		-		583,865		-			583,865

Net loss		-		-		-		(5,450,910	)		(5,450,910	)
Balance - March 31, 2020		19,776,019	$	1,977	$	75,445,289	$	(63,121,962	)	$	12,325,304

[1] Includes gross proceeds of $5,984,931, less total issuance costs of $533,189.

The accompanying notes are an integral part of these condensed financial statements.

EYENOVIA, INC.

Condensed Statements of Cash Flows

(unaudited)

	For the Three Months Ended
	March 31,
		2021			2020
Cash Flows From Operating Activities
Net loss	$	(5,351,667	)	$	(5,450,910	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property and equipment		33,281			28,229
Stock-based compensation		656,913			583,865
Changes in operating assets and liabilities:
Prepaid expenses and other current assets		(251,091	)		(189,021	)
License fee and expense reimbursements receivables		2,057,808			-
Deferred license costs		800,000			-
Accounts payable		353,452			(288,600	)
Accrued compensation		(579,940	)		(568,864	)
Accrued expenses and other current liabilities		(291,600	)		(32,623	)
Deferred license fee		(2,000,000	)		-
Deferred rent		(1,002	)		(3	)

Net Cash Used In Operating Activities		(4,573,846	)		(5,917,927	)

Cash Flows From Investing Activities
Purchases of property and equipment [1]		(344,320	)		(93,930	)
Net Cash Used In Investing Activities		(344,320	)		(93,930	)

Cash Flows From Financing Activities
Proceeds from sale of common stock and warrants in private placement [2]		-			5,569,136
Proceeds from exercise of stock warrants		1,530,990			-
Repayments of notes payable		(77,604	)		(52,051	)
Payment of offering issuance costs		-			(1,738	)

Net Cash Provided By Financing Activities		1,453,386			5,515,347
Net Decrease in Cash and Cash Equivalents		(3,464,780	)		(496,510	)
Cash and cash equivalents - Beginning of Period		28,371,828			14,152,601
Cash and cash equivalents - End of Period	$	24,907,048		$	13,656,091

Supplemental Disclosure of Cash Flow Information:
Cash paid during the periods for:
Interest	$	3,997	$	1,699

Supplemental Disclosure of Non-Cash Investing and Financing Activities
Accrual of private placement offering costs	$	-	$	115,656
Purchase of insurance premium financed by note payable	$	705,360	$	475,216

[1] Includes $203,799 of leasehold improvements and $140,521 of equipment purchases for the three months ended March 31, 2021.

[2] Includes gross proceeds of $5,984,931, less issuance costs of $415,795 deducted directly from the private placement proceeds.

The accompanying notes are an integral part of these condensed financial statements.

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 1 – Business Organization, Nature of Operations and Basis of Presentation

Eyenovia, Inc. (“Eyenovia” or the “Company”) is a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its propriety array print (MAP^TM) platform technology. Eyenovia aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet^®, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. In the clinical trials, the Optejet has demonstrated that Eyenovia’s targeted horizontal microdose delivery can achieve a significantly higher rate of successful ocular topical delivery compared to the established rate reported with traditional eye drops (~ 90% vs. ~ 50%). Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations where there are currently no comparable drug therapies approved by the U.S. Food and Drug Administration (the “FDA”). Eyenovia’s microdose therapeutics follow the FDA-designated pharmaceutical registration and regulatory process. Its products are classified by the FDA as drugs, and not medical devices or drug-device combination products.

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed financial statements of the Company as of March 31, 2021 and for the three months ended March 31, 2021 and 2020. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the operating results for the full year ending December 31, 2021 or any other period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and related disclosures of the Company as of December 31, 2020 and for the year then ended, which were included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 30, 2021.

Note 2 – Summary of Significant Accounting Policies

Since the date of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, there have been no material changes to the Company’s significant accounting policies, except as disclosed below.

Liquidity and Going Concern

As of March 31, 2021, the Company had cash of approximately $24.9 million and an accumulated deficit of approximately $82.8 million. For the three months ended March 31, 2021 and 2020, the Company incurred net losses of approximately $5.4 million and $5.5 million, respectively, and used cash in operations of approximately $4.6 million and $5.9 million, respectively. The Company does not have recurring revenue and has not yet achieved profitability. The Company expects to continue to incur cash outflows from operations. The Company expects that its research and development and general and administrative expenses will continue to increase and, as a result, it will eventually need to generate significant product revenues to achieve profitability. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date that these financial statements are issued. Implementation of the Company’s plans and its ability to continue as a going concern will depend upon the Company’s ability to raise further capital, through the sale of additional equity or debt securities or otherwise, to support its future operations.

The Company’s operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The Company’s future capital requirements and the adequacy of its available funds will depend on many factors, including the Company’s ability to successfully commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement its product and service offerings. If the Company is unable to secure additional capital, it may be required to curtail its research and development initiatives and take additional measures to reduce costs in order to conserve its cash.

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents in the financial statements.

The Company has cash deposits in a financial institution which, at times, may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company has not experienced losses in such accounts and periodically evaluates the creditworthiness of its financial institutions. As of March 31, 2021 and December 31, 2020, the Company had cash balances in excess of FDIC insurance limits of $24,657,048 and $28,121,828, respectively.

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period plus fully vested shares that are subject to issuance for little or no monetary consideration. Diluted earnings per share reflects the potential dilution that could occur if securities or other instruments to issue common stock were exercised or converted into common stock.

The following securities are excluded from the calculation of weighted average diluted common shares because their inclusion would have been anti-dilutive:

	March 31,
	2021		2020
Options		3,429,342		2,262,438
Warrants		1,366,321		3,344,154
Restricted stock units		105,306		60,355
Total potentially dilutive shares		4,900,969		5,666,947

Revenue Recognition

Our revenues are generated primarily through research, development and commercialization agreements. The terms of such agreements may contain multiple promised goods and services, which may include (i) licenses to our intellectual property, and (ii) in certain cases, payment in connection with the manufacturing and delivery of clinical supply materials. Payments to us under these arrangements typically include one or more of the following: non-refundable, upfront license fees; milestone payments; payments for clinical product supply, and royalties on future product sales.

We analyze our arrangements to assess whether such arrangements involve joint operating activities. For collaboration arrangements that are deemed to be within the scope of Accounting Standards Codification (“ASC”) Topic 808, “Collaborative Arrangements” (“ASC 808”), we allocate the contract consideration between such joint operating activities and elements that are reflective of a vendor-customer relationship and, therefore, within the scope of ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). Our policy is to recognize amounts allocated to joint operating activities as a reduction in research and development expense.

Under ASC 606, we recognize revenue when our customers obtain control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements that we determine are within the scope of ASC 606, we perform the following five steps:

	·	Step 1: Identify the contract with the customer;
	·	Step 2: Identify the performance obligations in the contract;
	·	Step 3: Determine the transaction price;
	·	Step 4: Allocate the transaction price to the performance obligations in the contract; and
	·	Step 5: Recognize revenue when the company satisfies a performance obligation.

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

We must make significant judgments in our revenue recognition process, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each performance obligation. In addition, arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered discretionary purchase options. We assess if these options provide a material right to the customer and if so, they are considered performance obligations.

For upfront license fees, we must consider how many performance obligations are in the contract and, if more than one, how to allocate the fee to those performance obligations upon satisfaction of the performance obligation(s). Milestone payments represent variable consideration that will be recognized when the performance obligation is achieved. Sales-based royalty payments derived from usage of intellectual property are recognized when those sales occur.

During 2020, the Company entered into a license agreement (the “Arctic Vision License Agreement”) with Arctic Vision (Hong Kong) Limited (“Arctic Vision”) and a license agreement (the “Bausch License Agreement”) with Bausch Health Companies, Inc. (“Bausch Health”). Each license has three revenue components: 1) an upfront license fee; 2) milestone payments; and 3) royalty payments. See Note 7 – Commitments and Contingencies for additional details.

Deferred License Fee

The Company enters into license agreements which provide for the receipt of non-refundable, upfront licensing payments. These payments are recorded as deferred license fees and will be earned and recognized as revenue upon the satisfaction of performance obligations. See Note 7 – Commitments and Contingencies for additional details.

Deferred License Costs

The Company enters into license agreements which provide for payment of license costs in connection with the Company’s receipt of license fees. These payments are recorded as deferred license costs and will be recorded as an expense when the related license fee revenue is recognized. See Note 8 – Related Party Transactions for additional details.

Recently Adopted Accounting Standards

In August 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-13 “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements based on the concepts in the FASB Concepts Statement, including the consideration of costs and benefits. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments are effective for fiscal years beginning after December 15, 2020. The Company adopted ASU 2018-13 effective January 1, 2021. This standard did not have a material impact on the Company’s financial position, results of operations or cash flow.

Recently Issued Accounting Standards

In February 2016, the FASB issued ASU 2016-02 “Leases (Topic 842)” (“ASU 2016-02”). ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02, as amended, is now effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. The FASB issued ASU 2019-01 “Leases (Topic 842) Codification Improvements” in March 2019 and ASU 2018-10 “Codification Improvements to Topic 842, Leases” and ASU 2018-11 “Leases (Topic 842) Targeted Improvements” in July 2018, and ASU 2018-20 “Leases (Topic 842) - Narrow Scope Improvements for Lessors” in December 2018. ASU 2019-01, ASU 2018-10 and ASU 2018-20 provide certain amendments that affect narrow aspects of the guidance issued in ASU 2016-02. ASU 2018-11 allows all entities adopting ASU 2016-02 to choose an additional (and optional) transition method of adoption, under which an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The Company is currently evaluating ASU 2016-02 and its impact on its financial position, results of operations, and cash flows.

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. The Company is currently evaluating ASU 2019-12 and its impact on its financial position, results of operations, and cash flows.

Note 3 – Prepaid Expenses and Other Current Assets

As of March 31, 2021 and December 31, 2020, prepaid expenses and other current assets consisted of the following:

	March 31,		December 31,
	2021		2020
Payroll tax receivable	$	270,682	$	151,942
Prepaid insurance expenses		863,119		110,094
Prepaid general and administrative expenses		109,918		-
Prepaid licenses and subscriptions		-		57,051
Prepaid conference expenses		21,603		29,403
Prepaid board of directors expenses		69,353		68,250
Prepaid rent and security deposit		25,004		25,004
Other		50,250		11,734
Total prepaid expenses and other current assets	$	1,409,929	$	453,478

Note 4 – Accrued Compensation

As of March 31, 2021 and December 31, 2020, accrued compensation consisted of the following:

	March 31,		December 31,
	2021		2020
Accrued bonus expenses	$	284,698	$	938,873
Accrued payroll expenses		286,034		211,799
Total accrued compensation	$	570,732	$	1,150,672

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 5 – Accrued Expenses and Other Current Liabilities

As of March 31, 2021 and December 31, 2020, accrued expenses and other current liabilities consisted of the following:

	March 31,		December 31,
	2021		2020
Accrued research and development expenses	$	1,119,083	$	348,254
Accrued consulting and professional services		18,167		235,355
Credit card payable		34,523		50,002
Accrued franchise tax		13,100		32,480
Accrued licensing fees		-		804,447
Accrued interest		4,219		3,068
Accrued expense reimbursements		-		5,459
Other		-		1,627
Total accrued expenses and other current liabilities	$	1,189,092	$	1,480,692

Note 6 – Notes Payable

As of March 31, 2021 and December 31, 2020, notes payable consisted of the following:

	March 31, 2021						December 31, 2020
		Current		Non-Current				Current		Non-Current
		Portion		Portion		Total		Portion		Portion		Total
BankDirect Capital Finance loan	$	627,756	$	-	$	627,756	$	-	$	-	$	-
Paycheck Protection Program loan		156,062		307,291		463,353		97,539		365,814		463,353
Total	$	783,818	$	307,291	$	1,091,109	$	97,539	$	365,814	$	463,353

On February 24, 2021, the Company issued a note payable for the purchase of a directors and officers liability insurance policy. The note payable is payable in nine monthly payments consisting of principal and interest amounting to $79,343 for an aggregate principal amount of $705,360. The note accrues interest at a rate of 2.96% per year and matures on November 24, 2021.

On May 8, 2020, the Company received cash proceeds of $463,353 pursuant to a loan provided in connection with the Paycheck Protection Program under the CARES Act (the “PPP Loan”). The PPP Loan provides for monthly installment payments of $19,508 beginning in August 2021 with the remaining balance due on May 3, 2022, the maturity date. The PPP Loan bears interest at a fixed rate of 1.00% per annum.

Under the terms of the CARES Act, as amended by the Paycheck Protection Program Flexibility Act of 2020, the Company is eligible to apply for and receive forgiveness for all or a portion of its PPP Loan. The Company applied for loan forgiveness on the PPP Loan in March 2021. Such forgiveness will be determined, subject to limitations, based on the use of the loan proceeds for certain permissible purposes as set forth in the PPP Loan, including, but not limited to, payroll costs and mortgage interest, rent or utility costs (collectively, “Qualifying Expenses”) incurred during the 24 weeks subsequent to funding, and on the maintenance of employee and compensation levels following the funding of the PPP Loan. The Company has used the proceeds of its PPP Loan for Qualifying Expenses. However, no assurance is provided that the Company will be able to obtain forgiveness of its PPP Loan in whole or in part. Any amounts that are not forgiven incur interest at 1.0% per annum and monthly repayments of principal and interest are deferred until six months after the Small Business Administration makes a determination on forgiveness. While the PPP Loan currently has a two-year maturity, the amended law permits the borrower to request a five-year maturity from its lender. During the three months ended March 31, 2021 and 2020, the Company recorded interest expense of $1,151 and $0, respectively.

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 7 – Commitments and Contingencies

See Note 8 – Related Party Transactions for certain commitments and contingencies entered into with certain related parties.

Litigations, Claims and Assessments

The Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. The Company records legal costs associated with loss contingencies as incurred and accrues for all probable and estimable settlements.

Arctic Vision License Agreement

On August 10, 2020, the Company entered into the Arctic Vision License Agreement pursuant to which Arctic Vision may develop and commercialize MicroPine for the treatment of progressive myopia and MicroLine for the treatment of presbyopia in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea.

Under the terms of the Arctic Vision License Agreement, the Company received a non-refundable, upfront payment of $4.0 million, before any payments to Senju Pharmaceutical Co., Ltd. (“Senju”), due under the Exclusive License Agreement between the Company and Senju, as amended on April 8, 2020 and a Letter Agreement dated August 10, 2020 (the “Senju License Agreement”). The Company had recorded the $4.0 million payment as a deferred license fee until the payment is earned. The Company considers payment earned once certain trial data has been fully submitted to Arctic Vision, permitting Arctic Vision to obtain regulatory approval with the National Medical Products Administration. The trial data for one of the two products (MicroPine) was fully submitted to Arctic Vision by March 31, 2021. Therefore, one half of the upfront payment, or $2.0 million, has been earned. As a result, the Company will recognize $2.0 million of deferred license fees and recognize $0.8 million of deferred license costs related to the Senju payment as of March 31, 2021.

In addition, the Company may receive up to a total of $41.75 million in additional payments, based on various development and regulatory milestones, including the initiation of clinical research and approvals in Greater China and South Korea, and development costs.

Arctic Vision also will purchase its supply of MicroPine and MicroLine from the Company or, for such products not supplied by the Company, pay the Company a mid-single digit percentage royalty on net sales of such products, subject to certain adjustments. No royalty payments were earned through March 31, 2021. The Company will pay a mid-double digit percentage of such payments, royalties, or net proceeds of such supply to Senju pursuant to the Senju License Agreement. See Note 8 – Related Party Transactions for additional details.

Bausch License Agreement

On October 9, 2020, the Company entered into the Bausch License Agreement pursuant to which Bausch Health may develop and commercialize the Bausch Licensed Product in the Licensed Territory.

In connection with the Bausch License Agreement, Bausch Health paid the Company a non-refundable, upfront payment of $10.0 million. The Company has recorded this payment as a deferred license fee until the payment is earned. The Company will consider payment earned once certain trial data has been fully submitted to Bausch Health and certain administrative functions are transferred to Bausch Health, permitting Bausch Health to assume supervisory oversight of the ongoing MicroPine study (the CHAPERONE study). The upfront payment had not been earned as of March 31, 2021.

Bausch Health could also pay the Company up to an aggregate of approximately $35.0 million in additional payments, depending on the achievement of certain regulatory and launch-based milestones. No milestone payments were earned through March 31, 2021.

Under the terms of the Bausch License Agreement, on a country-to-country basis and Bausch Licensed Product-by- Bausch Licensed Product basis, Bausch Health will pay the Company royalties on a tiered basis (ranging from mid-single digit to mid-teen percentages) on gross profits from the sales of the Bausch Licensed Product in the Licensed Territory, subject to certain adjustments in the event of generic entry, negative gross profits or patent expiration, for a period of the later to occur of the 10th anniversary of the first commercial sale of a Bausch Licensed Product in such country in the Licensed Territory or the expiration of the last valid patent claim for a Bausch Licensed Product in such country in the Licensed Territory. No royalty payments were earned through March 31, 2021.

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 8 – Related Party Transactions

Lease Agreements

The Company’s Vice President of Research and Development and Manufacturing (“VP of R&D”) owns a company that entered into a lease agreement with the Company on September 15, 2016 to lease 953 square feet of space located in Reno, Nevada with respect to its research and development activities. The initial monthly base rent was $3,895 per month over the term of the lease and the security deposit was $3,895. On September 15, 2018, the Company amended the lease agreement to extend it until September 14, 2020 and increase the monthly base rent and security deposit to $4,012. On September 15, 2020, the Company amended the lease agreement to extend it until September 14, 2022 and increase the monthly base rent and security deposit to $5,404. The Company made $82,500 of leasehold improvements related to this lease which are included on the condensed balance sheet. The Company’s rent expense for this space is recorded in Research and Development on the condensed statement of operations and amounted to $17,020 and $12,036 for the three months ended March 31, 2021 and 2020, respectively.

Senju License Agreement

During 2015, the Company entered into an Exclusive License Agreement with Senju whereby the Company agreed to grant to Senju an exclusive, royalty-bearing license for its microdose product candidates for Asia to sublicense, develop, make, have made, manufacture, use, import, market, sell, and otherwise distribute the microdose product candidates. In consideration for the license, Senju agreed to pay to Eyenovia five percent (5%) royalties for the term of the license agreement. The agreement will continue in full force and effect, on a country-by-country basis, until the latest to occur of: (i) the tenth (10th) anniversary of the first commercial sale of a microdose product candidate in Asia; or (ii) the expiration of the licensed patents. As of the date of this filing, there had been no commercial sales of a microdose product candidate in Asia, such that no royalties had been earned. Senju is owned by the family of a former member of the Company’s Board of Directors and, together, they beneficially own greater than 5% of the Company’s common stock.

On April 8, 2020, Eyenovia entered into an amendment (the “License Amendment”) to the Exclusive License Agreement. Pursuant to the License Amendment, the Company can license to any third party the right to research, develop, commercialize, manufacture or use certain products identified below (the “Senju Licensed Products”) previously licensed to Senju in China (including the People’s Republic of China, Hong Kong, Macao, and Taiwan) and South Korea (the “Territory”) if such a license is executed by the Company by April 8, 2021. The Senju Licensed Products are those using piezo-print technology in a microdose dispenser with (i) atropine sulfate as its sole active ingredient to treat myopia in humans and (ii) pilocarpine as its sole active ingredient to treat presbyopia in humans.

Pursuant to the License Amendment, the Company must pay Senju (a) close to a mid-double digit percentage of revenue on any lump-sum payments the Company receives from the third party, revenue (net of costs) obtained by the Company from contract research and/or development of the Senju Licensed Product in the Territory, and revenue (net of costs) obtained by the Company from contract manufacture for the device of the Senju Licensed Product in the Territory, the aggregate of which must be at least a high seven figure dollar amount minimum payment to Senju; and (b) a lower-double digit percentage of any sales royalty revenue the Company receives from the third party. Since the Company executed a third-party license prior to April 8, 2021, the License Amendment will remain in effect for the duration of the license, subject to early termination.

The Exclusive License Agreement was further amended in a Letter Agreement by and between the Company and Senju on August 10, 2020 (the “Letter Agreement”). Pursuant to the Letter Agreement, the Company will pay a mid-double digit percentage of certain payments, royalties, or net proceeds received from Arctic Vision in connection with the Arctic Vision License Agreement to Senju.

See Note 7 – Commitments and Contingencies – Arctic Vision License Agreement for additional details.

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 9 – Stockholders’ Equity

Securities Purchase Agreement

On March 24, 2020, the Company closed on a private placement of approximately $6.0 million of Units. Each Unit consists of (i) one share of the Company’s common stock, (ii) a one-year warrant to purchase 0.5 of a share of common stock (“Class A Warrant”), and (iii) a five-year warrant to purchase 0.75 of a share of common stock (“Class B Warrant”) (collectively, the Class A Warrants and Class B Warrants, the “Warrants”). The Units were sold to the public at a price of $2.21425 per Unit and to certain directors and executive officers at a price of $2.42625 per Unit. The Company generated approximately $5.3 million of net proceeds in the offering after deducting placement agent fees and offering expenses. In the offering, the Company issued an aggregate of 2,675,293 shares of common stock, Class A Warrants to purchase up to 1,337,659 shares of common stock, and Class B Warrants to purchase up to 2,006,495 shares of common stock. The exercise price of the Class A Warrants issued to the public is $2.058 per share and the exercise price of the Class A Warrants issued to the directors and officers is $2.27 per share. The exercise price of the Class B Warrants issued to the public is $2.4696 per share and the exercise price of the Class B Warrants issued to the directors and officers is $2.724 per share.

In connection with the private placement, on March 23, 2020, the Company also entered into a Registration Rights Agreement with the investors. Pursuant to the Registration Rights Agreement, the Company must file with the SEC, no later than 30 days following the date on which the Company files its Form 10-K for the year ended December 31, 2019 with the SEC, a registration statement on Form S-3 covering the shares of common stock issued in the offering and the shares of common stock underlying the Warrants. The Company timely filed the registration statement on Form S-3 (Registration Statement No. 333-237790), which was declared and has remained effective with the SEC since May 13, 2020.

Stock Options

In applying the Black-Scholes option pricing model to stock options granted, the Company used the following approximate assumptions:

	For the Three Months Ended
	March 31,
	2021			2020
Expected term (years)		5.85			5.85
Risk free interest rate		0.92	%		1.32	%
Expected volatility		94	%		101	%
Expected dividends		0.00	%		0.00	%

The Company has computed the fair value of stock options granted using the Black-Scholes option pricing model. Option forfeitures are accounted for at the time of occurrence. The expected term is the estimated period of time that options granted are expected to be outstanding. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee option grants. The Company does not yet have a trading history to support its historical volatility calculations. Accordingly, the Company is utilizing an expected volatility figure based on a review of the historical volatility of comparable entities over a period of time equivalent to the expected life of the instrument being valued. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.

The weighted average estimated grant date fair value of the stock options granted for the three months ended March 31, 2021 and 2020 was approximately $3.82 and $4.13 per share, respectively.

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

A summary of the option activity during the three months ended March 31, 2021 is presented below:

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
	Number of		Exercise		Life		Intrinsic
	Options		Price		In Years		Value
Outstanding January 1, 2021		3,427,705	$	3.37
Granted		1,637		5.11
Outstanding March 31, 2021		3,429,342	$	3.37		7.7	$	7,126,014

Exercisable March 31, 2021		1,862,537	$	3.54		6.7	$	3,889,820

The following table presents information related to stock options as of March 31, 2021:

	Options Outstanding		Options Exercisable
			Weighted
		Outstanding	Average	Exercisable
	Exercise	Number of	Remaining Life	Number of
	Price	Options	In Years	Options
$	1.24	260,000	4.0	260,000
$	1.95	673,544	6.3	673,544
$	2.72	764,419	-	-
$	2.74	6,000	7.8	4,333
$	2.89	263,500	-	-
$	3.11	659,849	8.4	369,646
$	3.43	58,920	-	-
$	3.48	45,000	-	-
$	3.71	43,000	-	-
$	4.00	2,000	7.6	1,556
$	4.68	25,000	8.8	9,029
$	5.10	6,000	7.4	5,000
$	5.11	1,637	-	-
$	5.19	16,500	7.4	13,750
$	5.25	26,668	5.5	26,668
$	5.77	50,000	-	-
$	6.20	300,387	7.3	283,298
$	6.30	60,000	7.3	53,333
$	8.72	166,918	7.0	162,380
		3,429,342	6.7	1,862,537

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Warrants

A summary of the Warrant activity for the three months ended March 31, 2021 is presented below:

						Weighted
				Weighted		Average
				Average		Remaining		Aggregate
	Number of			Exercise		Life		Intrinsic
	Warrants			Price		In Years		Value
Outstanding January 1, 2021		2,011,313		$	2.43
Exercised		(644,992	)		2.37
Outstanding March 31, 2021		1,366,321		$	2.51		4.0	$	3,530,228

Exercisable March 31, 2021		1,366,321		$	2.51		4.0	$	3,530,228

The following table presents information related to Warrants as of March 31, 2021:

	Warrants Outstanding		Warrants Exercisable
			Weighted
		Outstanding	Average	Exercisable
	Exercise	Number of	Remaining Life	Number of
	Price	Warrants	In Years	Warrants
$	2.4696	1,149,941	4.0	1,149,941
$	2.7240	216,380	4.0	216,380
		1,366,321	4.0	1,366,321

Stock-Based Compensation Expense

The Company recorded stock-based compensation expense related to stock options and restricted stock units of $656,913 ($329,713 of which was included within research and development expenses and $327,200 was included within general and administrative expenses on the condensed statements of operations) and $583,865 ($307,409 of which was included within research and development expenses and $276,456 was included within general and administrative expenses on the condensed statements of operations) during the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, there was $3,069,508 of unrecognized stock-based compensation expense which the Company expects to recognize over a weighted average period of 1.8 years.

Note 10 – Employee Benefit Plans

401(k) Plan

In April 2019, the Company adopted the Eyenovia 401(k) Plan (the “Plan”), which went into effect in May 2019. All Company employees are able to participate in the Plan, subject to eligibility requirements as outlined in the Plan documents. Under the terms of the Plan, eligible employees are able to defer a percentage of their pay every pay period up to annual limitations set by Congress and the Internal Revenue Service under Section 401(k) of the Internal Revenue Code. For 2021, the Company’s Board of Directors has approved a matching contribution equal to 100% of elective deferrals up to 4% of eligible earnings with the matching contribution subject to certain vesting requirements as outlined in the Plan documents. During the three months ended March 31, 2021 and 2020, the Company recorded expense of $64,178 and $57,971 associated with its matching contributions, respectively.

EYENOVIA, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

Note 11 – Subsequent Events

Stock Warrant Exercises

Subsequent to March 31, 2021, the Company issued an aggregate of 232,022 shares of common stock pursuant to the exercise of warrants for aggregate proceeds of $573,001 at an exercise price of $2.4696.

Loan and Security Agreement

On May 7, 2021, the Company entered into a Loan and Security Agreement (the “Loan”) with Silicon Valley Bank (the “Lender”) for an aggregate principal amount of up to $25.0 million. The Loan bears interest at annual rate equal to the greater of (a) the sum of 1.25% plus the prime rate as reported in The Wall Street Journal and (b) 5.00%. The Loan matures on May 1, 2025. The initial tranche in the amount of $7.5 million was received by the Company on May 7, 2021. In connection with the Loan, the Company issued to the Lender warrants to purchase 91,884 shares of common stock at an exercise price per share equal to $4.76. The warrants are exercisable for a period of ten years from the date of issuance. At the Company’s option, Eyenovia has the ability to draw down the remaining $17.5 million in gross proceeds in two tranches over the next two years based upon the achievement of several milestones in accordance with the terms of the agreement.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion and analysis of the results of operations and financial condition of Eyenovia, Inc. (“Eyenovia,” the “Company,” “we,” “us” and “our”) as of March 31, 2021 and for the three months ended March 31, 2021 and 2020 should be read in conjunction with our unaudited condensed financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q and with our audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the Securities and Exchange Commission (“SEC”) on March 30, 2021.

Forward Looking Statements

This report contains “forward-looking statements.” Specifically, all statements other than statements of historical facts included in this report, including regarding our financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. These forward-looking statements are based on the beliefs of management at the time these statements were made, as well as assumptions made by and information currently available to management. When used in this report, the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “might,” “will,” “continue” “intend,” and “plan” and words or phrases of similar import are intended to identify forward-looking statements. These statements reflect our current view with respect to future events and are subject to risks, uncertainties and assumptions related to various factors that could cause actual results and the timing of events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the section titled “Risk Factors” included in our most recent Annual report on Form 10-K filed with the SEC. Furthermore, such forward-looking statements speak only as of this Quarterly Report on Form 10-Q. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

Overview

We are a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on our proprietary microdose array print (MAP™) platform technology. We aim to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using our high-precision targeted ocular delivery system, branded the Optejet®. Optejet µ-therapeutics have the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. In the clinical trials, the Optejet has demonstrated that our targeted horizontal microdose delivery can achieve a significantly higher rate of successful ocular topical delivery compared to the established rate reported with traditional eye drops (~ 90% vs. ~ 50%). Our technology is designed to achieve single-digit µl-volume physiologic drug delivery with up to a 75% reduction in ocular drug and preservative topical dosing and has demonstrated significant improvement in the therapeutic index in drugs used for mydriasis and IOP lowering through three Phase II and Phase III trials. Conventional eye formulations lack high-precision micro-volume delivery and expose the ocular surface to approximately 300% more medication and preservatives than are physiologically indicated leading to clinically recognized ocular and non-ocular side effects. Using the Optejet, we are developing the next generation of smart ophthalmic therapeutics which target new indications or new combinations where there are currently no comparable drug therapies approved by the U.S. Food and Drug Administration, or the FDA. Our microdose therapeutics follow the FDA-designated pharmaceutical registration and regulatory process. Our products are classified by the FDA as drugs, and not medical devices or drug-device combination products.

Our pipeline is currently focused on the late-stage development of novel, potential first-in-class therapeutic indications for an estimated over five million potential patients with progressive myopia in the United States and estimated over one hundred million potential patients with age-related near vision impairment, or presbyopia – indications where there is tremendous unmet need and no known existing FDA-approved therapies. We are also developing the first microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the estimated over 100 million annual comprehensive eye exams with pupil dilation.

MicroPine is our first-in-class topical therapy for the treatment of progressive myopia, a back-of-the-eye ocular disease associated with pathologic axial elongation and sclero-retinal stretching. In the United States, myopia is estimated to affect approximately 25 million children, with up to five million considered to be at risk for high myopia. In February 2019, the FDA accepted our investigational new drug application, or IND, to initiate a Phase III registration trial of MicroPine (the CHAPERONE study) to reduce the progression of myopia in children. We enrolled the first patient in the CHAPERONE study in June 2019. Due to the COVID-19 pandemic, we previously experienced delays in trial enrollment and initiation as a result of reduced clinical trial activities and operations at investigator sites. However, we have since been able to resume enrollment in the CHAPERONE study.

On October 9, 2020, we entered into a License Agreement (the “Bausch License Agreement”) with a subsidiary of Bausch Health Companies Inc. (“Bausch Health”) pursuant to which Bausch Health may develop and commercialize MicroPine in the United States and Canada. Under the terms of the Bausch License Agreement, we received an upfront payment of $10.0 million and we may receive up to a total of $35.0 million in additional payments, based on the achievement of certain regulatory and launch-based milestones. Bausch Health also will pay us royalties on a tiered basis (ranging from mid-single digit to mid-teen percentages) on gross profits from sales of MicroPine in the United States and Canada, subject to certain adjustments. Under the terms of the Bausch License Agreement, Bausch Health is in the process of assuming oversight and has assumed the costs related to the ongoing CHAPERONE study.

MicroLine is our pharmacologic treatment for presbyopia. Presbyopia is a non-preventable, age-related hardening of the lens, which causes the gradual loss of the eye’s ability to focus at near and impairs near visual acuity. There currently are no known FDA-approved drugs for the improvement of near vision in patients with presbyopia, although other companies have related therapies in their pipeline. We have two planned Phase III VISION trials for MicroLine, and initiated the first of these trials in December 2020.

On August 10, 2020, we entered into a License Agreement (the “Arctic Vision License Agreement”) with Arctic Vision (Hong Kong) Limited (“Arctic Vision”), pursuant to which Arctic Vision may develop and commercialize MicroPine and MicroLine in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea. Under the terms of the Arctic Vision License Agreement, we received an upfront payment of $4.0 million before any payments to Senju Pharmaceutical Co., Ltd. (“Senju”). In addition, we may receive up to a total of $41.75 million in additional payments, based on various development and regulatory milestones, including the initiation of clinical research and approvals in Greater China and South Korea, and development costs. Arctic Vision also will purchase its supply of MicroPine and MicroLine from us or, for such products not supplied by us, pay us a mid-single digit percentage royalty on net sales of such products, subject to certain adjustments. We will pay a mid-double digit percentage of such payments, royalties, or net proceeds of such supply to Senju pursuant to the Exclusive License Agreement with Senju dated March 8, 2015, as amended by the License Amendment dated April 8, 2020, and a Letter Agreement dated August 10, 2020 (the “Senju License Agreement”).

MydCombi™ (or MicroStat) is our fixed combination formulation of phenylephrine-tropicamide for mydriasis, designed to be a novel approach for the estimated over one hundred million office-based comprehensive and diabetic eye exams performed every year in the United States. We have completed two Phase III trials for MydCombi and announced positive results from these studies, known as MIST-1 and MIST-2. In March 2021, the FDA accepted our new drug application, or NDA, for MydCombi with an expected Prescription Drug User Fee Act, or PDUFA, date of October 28, 2021.

We have not completed development of any product candidate and we have therefore not generated any revenues from product sales.

Historically, we have financed our operations principally through equity offerings, including our initial public offering, numerous public offerings in 2018, 2019 and August 2020, and our private placement that closed in March 2020. Recently we also have generated cash through licensing arrangements and our credit facility with Silicon Valley Bank. However, based upon our current operating plan, there is substantial doubt about our ability to continue as a going concern for a period of at least the next twelve months. Our ability to continue as a going concern depends on our ability to raise additional capital, through the sale of equity or debt securities to support our future operations. If we are unable to secure additional capital, we may be required to curtail our research and development initiatives and take additional measures to reduce costs.

Our net losses were $5.4 million for the three months ended March 31, 2021. As of March 31, 2021, we had working capital and an accumulated deficit of $11.7 million and $82.8 million, respectively.

Financial Overview

Revenue and Cost of Revenue

In August and October 2020, we entered into the Arctic Vision License Agreement and Bausch License Agreement, respectively. Both of these agreements provide for the Company to earn revenue from an upfront licensing fee, the achievement of various development and regulatory milestones, and royalty income on sales of licensed products. Pursuant to the Senju License Agreement, we will pay a mid-double digit percentage of such payments from the Arctic Vision License Agreement to Senju. See Note 7 – Commitments and Contingencies and Note 8 – Related Party Transactions.

Research and Development Expenses

Research and development expenses are incurred in connection with the research and development of our microdose-therapeutics and consist primarily of contract service expenses. Given where we are in our life cycle, we do not separately track research and development expenses by project. Our research and development expenses consist of:

direct clinical and non-clinical expenses, which include expenses incurred under agreements with contract research organizations, contract manufacturing organizations, and costs associated with preclinical activities, development activities and regulatory activities;

personnel-related expenses, which include expenses related to consulting agreements with individuals that have since entered into employment agreements with us as well as salaries and other compensation of employees that is attributable to research and development activities; and

facilities and other expenses, which include direct and allocated expenses for rent and maintenance of facilities, marketing, insurance and other supplies used in research and development activities.

We expense research and development costs as incurred. We record costs for some development activities, such as clinical trials, based on an evaluation of the progress to completion of specific tasks using data such as subject enrollment, clinical site activations or other information our vendors provide to us.

In addition, our license agreements with Arctic Vision and Bausch Health require them to assume or reimburse us for specified research and development costs.

We expect that our research and development expenses will increase with the continuation of the aforementioned initiatives.

General and Administrative Expenses

General and administrative expenses consist primarily of payroll and related expenses, legal and other professional services, as well as non-cash stock-based compensation expense. We anticipate that our general and administrative expenses will increase in the future as we increase our headcount to support our continued research and development and the potential commercialization of our product candidates. We also anticipate increased expenses related to audit, legal, regulatory, and tax-related services associated with maintaining compliance with exchange listing and SEC requirements. In addition, director and officer insurance premiums and investor relations costs associated with being a public company are expected to increase in future periods.

Results of Operations

Three Months Ended March 31, 2021 Compared with Three Months Ended March 31, 2020

Revenue and Cost of Revenue

In August 2020, we received a $4.0 million upfront payment under the Arctic Vision License Agreement, and made a related payment of $1.6 million to Senju. This upfront payment was recorded as $4.0 million of deferred license fee and $1.6 million of deferred cost of revenue. The trial data for one of the two products (MicroPine) was fully submitted to Arctic Vision during the three months ended March 31, 2021. Therefore, one half of the upfront payment, or $2.0 million, has been earned. As a result, the Company will recognize $2.0 million of deferred license fees and recognize $0.8 million of deferred license costs related to the Senju payment for the three months ended March 31, 2021. There was no revenue or cost of revenue for the three months ended March 31, 2020.

Research and Development Expenses

Research and development expenses for the three months ended March 31, 2021 totaled $4.2 million, an increase of $0.6 million, or 17%, as compared to $3.6 million recorded for the three months ended March 31, 2020.

Research and development expenses consisted of the following:

	For the Three Months Ended
	March 31,
	2021		2020
Direct clinical and non-clinical expenses	$	2,537,027	$	1,902,164
Personnel-related expenses		1,200,991		915,148
Supplies and materials		149,767		497,596
Non-cash stock-based compensation expenses		329,713		307,409
Other		30,228		11,970
Total research and development expenses	$	4,247,726	$	3,634,287

The increase in direct clinical and non-clinical expenses was primarily due to an increase in production and testing for MydCombi and the formulation of MicroLine and fewer COVID–19 restrictions. The increase in personnel-related expenses was primarily due to new hires. The decrease in supplies and materials was primarily due to there already being an adequate supply of materials required for the Chaperone study. The increase in non-cash stock-based compensation expense was primarily due to the amortization of several stock options granted in the second half of 2020.

General and Administrative Expenses

General and administrative expense for the three months ended March 31, 2021 totaled $2.3 million, an increase of $0.5 million, or 25%, as compared to $1.8 million recorded for the three months ended March 31, 2020. This increase was primarily attributable to a $0.2 million increase in personnel-related expenses which resulted from new hires and the increase in non-cash stock-based compensation expense, a $0.2 million increase in sales and marketing expenses mainly due to an increase in promotional materials and a $0.1 million increase in directors and officers insurance premium.

Liquidity and Capital Resources

Since inception, we have experienced negative cash flows from operations. As of March 31, 2021, our accumulated deficit since inception was $82.8 million.

As of March 31, 2021, we had a cash balance of $24.9 million, working capital of $11.7 million and stockholders’ equity of $12.1 million. As of March 31, 2021 and December 31, 2020, we had $1.1 million and $0.5 million, respectively, of debt outstanding.

These conditions raise substantial doubt about our ability to continue as a going concern for at least one year from the date that the financial statements included elsewhere in this Quarterly Report on Form 10-Q are issued. Our financial statements do not include adjustments to the amounts and classification of assets and liabilities that may be necessary should we be unable to continue as a going concern. Our ability to continue as a going concern depends on our ability to raise additional capital through the sale of equity or debt securities to support our future operations. Our operating needs include the planned costs to operate our business, including amounts required to fund research and development activities including clinical studies, working capital and capital expenditures. Our future capital requirements and the adequacy of our available funds will depend on many factors, including our ability to successfully commercialize our products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement our product and service offerings. If we are unable to secure additional capital, we may be required to curtail our research and development initiatives and take additional measures to reduce costs in order to conserve our cash.

During the three months ended March 31, 2021 and 2020, our sources and uses of cash were as follows:

Net cash used in operating activities for the three months ended March 31, 2021 was $4.6 million, which includes cash used to fund a net loss of $5.4 million, reduced by $0.7 million of non-cash expenses and $0.1 million of cash provided by changes in operating assets and liabilities. Net cash used in operating activities for the three months ended March 31, 2020 was $5.9 million, which includes cash used to fund a net loss of $5.5 million, reduced by $0.6 million of non-cash expenses, plus $1.1 million of cash used to fund changes in operating assets and liabilities.

Cash used in investing activities for the three months ended March 31, 2021 was $0.3 million, which was related to leasehold improvement expenditures and the purchase of property and equipment. There was less than $0.1 million used in investing activities for purchases of leasehold improvements and property and equipment for the three months ended March 31, 2020.

Net cash provided by financing activities for the three months ended March 31, 2021 totaled $1.5 million, which was mainly attributable to aggregate proceeds from the exercise of stock warrants. Cash provided by financing activities for the three months ended March 31, 2020 totaled $5.5 million, which was primarily attributable to aggregate proceeds from the sale of common stock and warrants in a private placement.

Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements between us and any other entity that have, or are reasonably likely to have, a current or future effect on financial conditions, changes in financial conditions, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

Critical Accounting Policies

For a description of our critical accounting policies, see Note 2 – Summary of Significant Accounting Policies in Part 1, Item 1 of this Quarterly Report on Form 10-Q.

Recently Adopted Accounting Standards

For a description of recently adopted accounting standards, including adoption dates and estimated effects, if any, on our condensed financial statements, see Note 2 – Summary of Significant Accounting Policies in Part 1, Item 1 of this Quarterly Report on Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Smaller reporting companies such as us are not required to provide the information required by this item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

In designing and evaluating our disclosure controls and procedures, management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Based on their evaluation, our principal executive officer and principal financial and accounting officer concluded that, as of March 31, 2021, our disclosure controls and procedures were designed to, and were effective to, provide assurance at a reasonable level that the information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer, as appropriate, to allow timely decisions regarding required disclosures as of March 31, 2021.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting that occurred during the first quarter of 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

Smaller reporting companies such as us are not required to provide the information required by this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Recent Sales of Unregistered Securities

None.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

Item 3. Defaults upon Senior Securities.

Not applicable.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

Exhibit		Incorporated by Reference (Unless Otherwise Indicated)
Number	Exhibit Description	Form	File No.	Exhibit	Filing Date

10.1#	Amendment to Executive Employment Agreement, dated February 1, 2021, by and between the Company and Michael M. Rowe	8-K	001-38365	10.1	February 3, 2021

31.1	Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	—	—	—	Filed herewith

31.2	Certification of the Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	—	—	—	Filed herewith

32.1	Certification of the Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	—	—	—	Filed herewith

32.2	Certification of the Principal Financial and Accounting Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	—	—	—	Filed herewith

101	Interactive data files pursuant to Rule 405 of Regulation S-T: (i) Condensed Balance Sheets as of March 31, 2021 and December 31, 2020; (ii) Condensed Statements of Operations for the Three Months Ended March 31, 2021 and 2020; (iii) Condensed Statements of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2021 and 2020; Condensed Statements of Cash Flows for the Three Months Ended March 31, 2021 and 2020; and (iv) Notes to Condensed Financial Statements	—	—	—	Filed herewith.

# Management contract or other compensatory plan.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	EYENOVIA, INC.

Date: May 14, 2021	By:	/s/ John Gandolfo
		John Gandolfo
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-31.1 2 tm2111695d1_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Tsontcho Ianchulev, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Eyenovia, Inc. for the quarterly period ended March 31, 2021;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting( as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 14, 2021	/s/ Tsontcho Ianchulev
	Name:	Tsontcho Ianchulev
	Title:	Chief Executive Officer
		(Principal Executive Officer)

EX-31.2 3 tm2111695d1_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John Gandolfo, certify that:

I have reviewed this Quarterly Report on Form 10-Q of Eyenovia, Inc. for the quarterly period ended March 31, 2021;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 14, 2021	/s/ John Gandolfo
	Name:	John Gandolfo
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-32.1 4 tm2111695d1_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of Eyenovia, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tsontcho Ianchulev, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 14, 2021	/s/ Tsontcho Ianchulev
	Name:	Tsontcho Ianchulev
	Title:	Chief Executive Officer
		(Principal Executive Officer)

EX-32.2 5 tm2111695d1_ex32-2.htm EXHIBIT 32.2

Exhibit 32.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of Eyenovia, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Gandolfo, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 14, 2021	/s/ John Gandolfo
	Name:	John Gandolfo
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-101.INS 6 eyen-20210331.xml XBRL INSTANCE DOCUMENT 0001682639 us-gaap:IPOMember 2020-03-24 2020-03-24 0001682639 eyen:ClassWarrantsMember 2020-03-24 2020-03-24 0001682639 eyen:ClassBWarrantsMember 2020-03-24 2020-03-24 0001682639 us-gaap:RetainedEarningsMember 2021-03-31 0001682639 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001682639 us-gaap:RetainedEarningsMember 2020-12-31 0001682639 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001682639 us-gaap:RetainedEarningsMember 2020-03-31 0001682639 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001682639 us-gaap:RetainedEarningsMember 2019-12-31 0001682639 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001682639 us-gaap:CommonStockMember 2021-03-31 0001682639 us-gaap:CommonStockMember 2020-12-31 0001682639 us-gaap:CommonStockMember 2020-03-31 0001682639 us-gaap:CommonStockMember 2019-12-31 0001682639 eyen:ExercisePriceTwoMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceThreeMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceTenMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceSixMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceSevenMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceOneMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceNineMemberMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceFourMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceFiveMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceElevenMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceEightMember 2021-01-01 2021-03-31 0001682639 eyen:ExercisePrice5.77Member 2021-01-01 2021-03-31 0001682639 eyen:ExercisePrice5.11Member 2021-01-01 2021-03-31 0001682639 eyen:ExercisePrice4.68Member 2021-01-01 2021-03-31 0001682639 eyen:ExercisePrice3.71Member 2021-01-01 2021-03-31 0001682639 eyen:ExercisePrice3.48Member 2021-01-01 2021-03-31 0001682639 eyen:ExercisePrice3.43Member 2021-01-01 2021-03-31 0001682639 eyen:ExercisePrice2.89Member 2021-01-01 2021-03-31 0001682639 eyen:ExercisePrice2.72Member 2021-01-01 2021-03-31 0001682639 eyen:ExercisePriceTwoMember 2021-03-31 0001682639 eyen:ExercisePriceThreeMember 2021-03-31 0001682639 eyen:ExercisePriceTenMember 2021-03-31 0001682639 eyen:ExercisePriceSixMember 2021-03-31 0001682639 eyen:ExercisePriceSevenMember 2021-03-31 0001682639 eyen:ExercisePriceOneMember 2021-03-31 0001682639 eyen:ExercisePriceNineMemberMember 2021-03-31 0001682639 eyen:ExercisePriceFourMember 2021-03-31 0001682639 eyen:ExercisePriceFiveMember 2021-03-31 0001682639 eyen:ExercisePriceElevenMember 2021-03-31 0001682639 eyen:ExercisePriceEightMember 2021-03-31 0001682639 eyen:ExercisePrice5.77Member 2021-03-31 0001682639 eyen:ExercisePrice5.11Member 2021-03-31 0001682639 eyen:ExercisePrice4.68Member 2021-03-31 0001682639 eyen:ExercisePrice3.71Member 2021-03-31 0001682639 eyen:ExercisePrice3.48Member 2021-03-31 0001682639 eyen:ExercisePrice3.43Member 2021-03-31 0001682639 eyen:ExercisePrice2.89Member 2021-03-31 0001682639 eyen:ExercisePrice2.72Member 2021-03-31 0001682639 us-gaap:StockOptionMember 2020-12-31 0001682639 us-gaap:StockOptionMember 2021-01-01 2021-03-31 0001682639 us-gaap:StockOptionMember 2021-03-31 0001682639 eyen:VicePresidentOfResearchAndDevelopmentMember 2020-09-15 0001682639 eyen:VicePresidentOfResearchAndDevelopmentMember 2018-09-15 0001682639 us-gaap:SubsequentEventMember 2021-05-01 2021-05-31 0001682639 us-gaap:LeaseholdImprovementsMember 2021-01-01 2021-03-31 0001682639 us-gaap:EquipmentMember 2021-01-01 2021-03-31 0001682639 eyen:VicePresidentOfResearchAndDevelopmentMember 2016-09-15 0001682639 eyen:LicenseAgreementMember 2015-12-31 0001682639 eyen:PaycheckProtectionProgramLoanMember 2021-03-31 0001682639 eyen:BankdirectCapitalFinanceLoanMember 2021-03-31 0001682639 eyen:PaycheckProtectionProgramLoanMember 2020-12-31 0001682639 eyen:BankdirectCapitalFinanceLoanMember 2020-12-31 0001682639 eyen:SiliconValleyBankMember us-gaap:SubsequentEventMember us-gaap:PrimeRateMember 2021-05-07 0001682639 eyen:VicePresidentOfResearchAndDevelopmentMember 2021-03-31 0001682639 eyen:VicePresidentOfResearchAndDevelopmentMember 2021-01-01 2021-03-31 0001682639 eyen:VicePresidentOfResearchAndDevelopmentMember 2020-01-01 2020-03-31 0001682639 eyen:SiliconValleyBankMember us-gaap:SubsequentEventMember 2021-05-07 2021-05-07 0001682639 srt:MinimumMember eyen:PaycheckProtectionProgramLoanMember 2020-05-08 2020-05-08 0001682639 srt:MaximumMember eyen:PaycheckProtectionProgramLoanMember 2020-05-08 2020-05-08 0001682639 us-gaap:NotesPayableOtherPayablesMember 2020-02-24 0001682639 us-gaap:SubsequentEventMember 2021-05-31 0001682639 eyen:ClassWarrantsMember us-gaap:IPOMember 2020-03-24 0001682639 eyen:ClassBWarrantsMember us-gaap:IPOMember 2020-03-24 0001682639 eyen:ClassWarrantsMember 2020-03-24 0001682639 eyen:ClassBWarrantsMember 2020-03-24 0001682639 2020-03-31 0001682639 2019-12-31 0001682639 us-gaap:WarrantMember 2021-01-01 2021-03-31 0001682639 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001682639 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0001682639 us-gaap:WarrantMember 2020-01-01 2020-03-31 0001682639 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0001682639 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0001682639 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001682639 us-gaap:ResearchAndDevelopmentExpenseMember 2021-01-01 2021-03-31 0001682639 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-03-31 0001682639 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-03-31 0001682639 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-03-31 0001682639 us-gaap:IPOMember 2020-03-24 0001682639 eyen:DirectorsAndExecutiveOfficersMember 2020-03-24 0001682639 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001682639 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001682639 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001682639 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001682639 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001682639 eyen:ArcticVisionLicenseAgreementMember 2021-01-01 2021-03-31 0001682639 eyen:SenjuPharmaceuticalCoMember 2015-01-01 2015-12-31 0001682639 eyen:CommonStockOneMember 2020-01-01 2020-03-31 0001682639 eyen:CommonStockOneMember 2020-01-01 2020-03-31 0001682639 eyen:PaycheckProtectionProgramLoanMember 2020-05-08 2020-05-08 0001682639 eyen:PaycheckProtectionProgramLoanMember 2020-05-08 0001682639 eyen:SiliconValleyBankMember us-gaap:SubsequentEventMember 2021-05-07 0001682639 us-gaap:NotesPayableOtherPayablesMember 2020-02-24 2020-02-24 0001682639 2020-03-24 2020-03-24 0001682639 eyen:BauschLicenseAgreementMember 2021-01-01 2021-03-31 0001682639 eyen:BauschLicenseAgreementMember 2020-10-09 2020-10-09 0001682639 eyen:ArcticVisionLicenseAgreementMember 2020-08-10 2020-08-10 0001682639 eyen:BauschLicenseAgreementMember 2020-10-09 0001682639 eyen:ArcticVisionLicenseAgreementMember 2020-08-10 0001682639 eyen:VicePresidentOfResearchAndDevelopmentMember 2020-09-15 2020-09-15 0001682639 eyen:VicePresidentOfResearchAndDevelopmentMember 2018-09-15 2018-09-15 0001682639 eyen:VicePresidentOfResearchAndDevelopmentMember 2016-09-01 2016-09-15 0001682639 eyen:ArcticVisionLicenseAgreementMember 2021-03-31 0001682639 eyen:SenjuLicenseAgreementMember 2020-08-10 0001682639 eyen:SenjuLicenseAgreementMember 2021-03-31 0001682639 eyen:ClassWarrantsMember us-gaap:IPOMember 2020-03-24 2020-03-24 0001682639 eyen:ClassBWarrantsMember us-gaap:IPOMember 2020-03-24 2020-03-24 0001682639 eyen:WarrantsAtExercisePriceThreeMember 2021-01-01 2021-03-31 0001682639 eyen:WarrantsAtExercisePriceFourMember 2021-01-01 2021-03-31 0001682639 eyen:WarrantsAtExercisePriceThreeMember 2021-03-31 0001682639 eyen:WarrantsAtExercisePriceFourMember 2021-03-31 0001682639 2021-03-31 0001682639 2020-12-31 0001682639 2020-01-01 2020-03-31 0001682639 2021-05-12 0001682639 2021-01-01 2021-03-31 utr:sqft xbrli:pure eyen:item iso4217:USD xbrli:shares iso4217:USD xbrli:shares false --12-31 Q1 2021 2021-03-31 10-Q 0001682639 25855599 Yes true false Non-accelerated Filer Yes EYENOVIA, INC. false true Common Stock, $0.0001 Par Value NASDAQ EYEN 115656 0 235355 18167 5459 0 1480692 1189092 32480 13100 804447 0 348254 1119083 1366321 1366321 216380 1149941 3530228 2.51 P4Y P4Y P4Y P4Y -644992 2.37 P5Y P1Y 3530228 2.43 2.51 P4Y 50002 34523 800000 <div> <div> Deferred License Costs The Company enters into license agreements which provide for payment of license costs in connection with the Company’s receipt of license fees. These payments are recorded as deferred license costs and will be recorded as an expense when the related license fee revenue is recognized. See Note 8 – Related Party Transactions for additional details. <div /></div> </div> <div> <div> Deferred License Fee The Company enters into license agreements which provide for the receipt of non-refundable, upfront licensing payments. These payments are recorded as deferred license fees and will be earned and recognized as revenue upon the satisfaction of performance obligations. See Note 7 – Commitments and Contingencies for additional details. <div /></div> </div> 4000000 2000000 <div> <div> As of March 31, 2021 and December 31, 2020, accrued compensation consisted of the following:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accrued bonus expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 284,698 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 938,873 </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accrued payroll expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 286,034 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 211,799 </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total accrued compensation </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 570,732 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,150,672 </td> </tr> </table></div>   <div /></div> </div> -3 -1002 0 -2057808 3895 4012 5404 41750000 35000000 4000000 10000000 2966039 908231 <div> <div> Liquidity and Going Concern As of March 31, 2021, the Company had cash of approximately $24.9 million and an accumulated deficit of approximately $82.8 million. For the three months ended March 31, 2021 and 2020, the Company incurred net losses of approximately $5.4 million and $5.5 million, respectively, and used cash in operations of approximately $4.6 million and $5.9 million, respectively. The Company does not have recurring revenue and has not yet achieved profitability. The Company expects to continue to incur cash outflows from operations. The Company expects that its research and development and general and administrative expenses will continue to increase and, as a result, it will eventually need to generate significant product revenues to achieve profitability. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date that these financial statements are issued. Implementation of the Company’s plans and its ability to continue as a going concern will depend upon the Company’s ability to raise further capital, through the sale of additional equity or debt securities or otherwise, to support its future operations. The Company’s operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The Company’s future capital requirements and the adequacy of its available funds will depend on many factors, including the Company’s ability to successfully commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement its product and service offerings. If the Company is unable to secure additional capital, it may be required to curtail its research and development initiatives and take additional measures to reduce costs in order to conserve its cash. <div /></div> </div> 0 5300000 <div> <div> Note 6 – Notes Payable As of March 31, 2021 and December 31, 2020, notes payable consisted of the following:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.58%;"> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:31.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="8" valign="bottom" style="width:28.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31, </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:31.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:28.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Non- </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Non- </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Current </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Current </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Current </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Current </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Portion </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Portion </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Portion </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Portion </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Total </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> BankDirect Capital Finance loan </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 627,756 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 627,756 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Paycheck Protection Program loan </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 156,062 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 307,291 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 463,353 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 97,539 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 365,814 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 463,353 </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 783,818 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 307,291 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,091,109 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 97,539 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 365,814 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 463,353 </td> </tr> </table></div>   On February 24, 2021, the Company issued a note payable for the purchase of a directors and officers liability insurance policy. The note payable is payable in nine monthly payments consisting of principal and interest amounting to $79,343 for an aggregate principal amount of $705,360. The note accrues interest at a rate of 2.96% per year and matures on November 24, 2021. On May 8, 2020, the Company received cash proceeds of $463,353 pursuant to a loan provided in connection with the Paycheck Protection Program under the CARES Act (the “PPP Loan”). The PPP Loan provides for monthly installment payments of $19,508 beginning in August 2021 with the remaining balance due on May 3, 2022, the maturity date. The PPP Loan bears interest at a fixed rate of 1.00% per annum. Under the terms of the CARES Act, as amended by the Paycheck Protection Program Flexibility Act of 2020, the Company is eligible to apply for and receive forgiveness for all or a portion of its PPP Loan. The Company applied for loan forgiveness on the PPP Loan in March 2021. Such forgiveness will be determined, subject to limitations, based on the use of the loan proceeds for certain permissible purposes as set forth in the PPP Loan, including, but not limited to, payroll costs and mortgage interest, rent or utility costs (collectively, “Qualifying Expenses”) incurred during the 24 weeks subsequent to funding, and on the maintenance of employee and compensation levels following the funding of the PPP Loan. The Company has used the proceeds of its PPP Loan for Qualifying Expenses. However, no assurance is provided that the Company will be able to obtain forgiveness of its PPP Loan in whole or in part. Any amounts that are not forgiven incur interest at 1.0% per annum and monthly repayments of principal and interest are deferred until six months after the Small Business Administration makes a determination on forgiveness. While the PPP Loan currently has a two-year maturity, the amended law permits the borrower to request a five-year maturity from its lender. During the three months ended March 31, 2021 and 2020, the Company recorded interest expense of $1,151 and $0, respectively. <div /></div> </div> P9M 2 1738 0 151942 270682 0.010 0.50 0.90 P168D 29403 21603 68250 69353 <div> <div> Note 3 – Prepaid Expenses and Other Current Assets As of March 31, 2021 and December 31, 2020, prepaid expenses and other current assets consisted of the following:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Payroll tax receivable </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 270,682 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 151,942 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Prepaid insurance expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 863,119 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 110,094 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Prepaid general and administrative expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 109,918 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Prepaid licenses and subscriptions </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 57,051 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Prepaid conference expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 21,603 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 29,403 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Prepaid board of directors expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 69,353 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 68,250 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Prepaid rent and security deposit </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 25,004 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 25,004 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Other </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 50,250 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 11,734 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total prepaid expenses and other current assets </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,409,929 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 453,478 </td> </tr> </table></div>   <div /></div> </div> 0 109918 57051 0 25004 25004 5984931 5984931 475216 705360 0.05 0 0 <div> <div> As of March 31, 2021 and December 31, 2020, notes payable consisted of the following:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.58%;"> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:31.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31, </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="8" valign="bottom" style="width:28.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31, </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:31.26%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:28.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Non- </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Non- </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Current </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Current </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Current </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Current </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Portion </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Portion </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Portion </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Portion </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:08.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Total </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> BankDirect Capital Finance loan </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 627,756 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 627,756 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Paycheck Protection Program loan </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 156,062 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 307,291 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 463,353 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 97,539 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 365,814 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 463,353 </td> </tr> <tr> <td valign="bottom" style="width:36.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 783,818 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 307,291 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,091,109 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 97,539 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 365,814 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 463,353 </td> </tr> </table></div>   <div /></div> </div> 2675293 644992 5451742 5451475 267 0 1530990 1530925 65 2.42625 2.21425

<div> <div> Note 5 – Accrued Expenses and Other Current Liabilities As of March 31, 2021 and December 31, 2020, accrued expenses and other current liabilities consisted of the following:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accrued research and development expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,119,083 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 348,254 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accrued consulting and professional services </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 18,167 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 235,355 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Credit card payable </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 34,523 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 50,002 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accrued franchise tax </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 13,100 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 32,480 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accrued licensing fees </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 804,447 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accrued interest </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,219 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,068 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accrued expense reimbursements </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,459 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Other </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,627 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total accrued expenses and other current liabilities </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,189,092 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,480,692 </td> </tr> </table></div>   <div /></div> </div>

1461665

1815117

938873

284698

1480692

1189092

211799

286034

92742306

94930144

583865

276456

307409

656913

327200

329713

533189

5666947

2262438

60355

3344154

4900969

3429342

105306

1366321

33906760

28851662

33391345

28025208

28371828

24907048

24900000

<div> <div> Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents in the financial statements. The Company has cash deposits in a financial institution which, at times, may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company has not experienced losses in such accounts and periodically evaluates the creditworthiness of its financial institutions. As of March 31, 2021 and December 31, 2020, the Company had cash balances in excess of FDIC insurance limits of  $24,657,048 and $28,121,828, respectively. <div /></div> </div>

14152601

13656091

28371828

24907048

-496510

-3464780

28121828

24657048

2.724

2.27

0.75

0.5

2.7240

2.4696

4.76

2.4696

91884

232022

2011313

1366321

216380

1149941

<div> <div> Note 7 – Commitments and Contingencies See Note 8 - Related Party Transactions for certain commitments and contingencies entered into with certain related parties. Litigations, Claims and Assessments The Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. The Company records legal costs associated with loss contingencies as incurred and accrues for all probable and estimable settlements. Arctic Vision License Agreement On August 10, 2020, the Company entered into the Arctic Vision License Agreement pursuant to which Arctic Vision may develop and commercialize MicroPine for the treatment of progressive myopia and MicroLine for the treatment of presbyopia in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea. Under the terms of the Arctic Vision License Agreement, the Company received a non-refundable, upfront payment of $4.0 million, before any payments to Senju Pharmaceutical Co., Ltd. ("Senju"), due under the Exclusive License Agreement between the Company and Senju, as amended on April 8, 2020 and a Letter Agreement dated August 10, 2020 (the “Senju License Agreement”). The Company had recorded the $4.0 million payment as a deferred license fee until the payment is earned. The Company considers payment earned once certain trial data has been fully submitted to Arctic Vision, permitting Arctic Vision to obtain regulatory approval with the National Medical Products Administration. The trial data for one of the two products (MicroPine) was fully submitted to Arctic Vision by March 31, 2021. Therefore, one half of the upfront payment, or $2.0 million, has been earned. As a result, the Company will recognize $2.0 million of deferred license fees and recognize $0.8 million of deferred license costs related to the Senju payment as of March 31, 2021.   In addition, the Company may receive up to a total of $41.75 million in additional payments, based on various development and regulatory milestones, including the initiation of clinical research and approvals in Greater China and South Korea, and development costs.   Arctic Vision also will purchase its supply of MicroPine and MicroLine from the Company or, for such products not supplied by the Company, pay the Company a mid-single digit percentage royalty on net sales of such products, subject to certain adjustments. No royalty payments were earned through March 31, 2021. The Company will pay a mid-double digit percentage of such payments, royalties, or net proceeds of such supply to Senju pursuant to the Senju License Agreement. See Note 8 – Related Party Transactions for additional details.   Bausch License Agreement On October 9, 2020, the Company entered into the Bausch License Agreement pursuant to which Bausch Health may develop and commercialize the Bausch Licensed Product in the Licensed Territory. In connection with the Bausch License Agreement, Bausch Health paid the Company a non-refundable, upfront payment of $10.0 million. The Company has recorded this payment as a deferred license fee until the payment is earned. The Company will consider payment earned once certain trial data has been fully submitted to Bausch Health and certain administrative functions are transferred to Bausch Health, permitting Bausch Health to assume supervisory oversight of the ongoing MicroPine study (the CHAPERONE study). The upfront payment had not been earned as of March 31, 2021. Bausch Health could also pay the Company up to an aggregate of approximately $35.0 million in additional payments, depending on the achievement of certain regulatory and launch-based milestones. No milestone payments were earned through March 31, 2021. Under the terms of the Bausch License Agreement, on a country-to-country basis and Bausch Licensed Product-by- Bausch Licensed Product basis, Bausch Health will pay the Company royalties on a tiered basis (ranging from mid-single digit to mid-teen percentages) on gross profits from the sales of the Bausch Licensed Product in the Licensed Territory, subject to certain adjustments in the event of generic entry, negative gross profits or patent expiration, for a period of the later to occur of the 10th anniversary of the first commercial sale of a Bausch Licensed Product in such country in the Licensed Territory or the expiration of the last valid patent claim for a Bausch Licensed Product in such country in the Licensed Territory. No royalty payments were earned through March 31, 2021. <div /></div> </div>

0.0001

90000000

24978585

25623577

24978585

25623577

2498

2563

<div> <div> Note 10 – Employee Benefit Plans 401(k) Plan In April 2019, the Company adopted the Eyenovia 401(k) Plan (the “Plan”), which went into effect in May 2019. All Company employees are able to participate in the Plan, subject to eligibility requirements as outlined in the Plan documents. Under the terms of the Plan, eligible employees are able to defer a percentage of their pay every pay period up to annual limitations set by Congress and the Internal Revenue Service under Section 401(k) of the Internal Revenue Code. For 2021, the Company’s Board of Directors has approved a matching contribution equal to 100% of elective deferrals up to 4% of eligible earnings with the matching contribution subject to certain vesting requirements as outlined in the Plan documents. During the three months ended March 31, 2021 and 2020, the Company recorded expense of $64,178 and $57,971 associated with its matching contributions, respectively. <div /></div> </div>

<div> <div> Note 4 – Accrued Compensation As of March 31, 2021 and December 31, 2020, accrued compensation consisted of the following:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:11.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:11.08%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accrued bonus expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 284,698 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 938,873 </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accrued payroll expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 286,034 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 211,799 </td> </tr> <tr> <td valign="bottom" style="width:71.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total accrued compensation </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.80%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 570,732 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,150,672 </td> </tr> </table></div>   <div /></div> </div>

14000000

12000000

800000

705360

25000000

0.0296

0.0100

0.0500

79343

19508

P5Y

P2Y

P10Y

17500000

<div> <div> As of March 31, 2021 and December 31, 2020, prepaid expenses and other current assets consisted of the following:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Payroll tax receivable </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 270,682 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 151,942 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Prepaid insurance expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 863,119 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 110,094 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Prepaid general and administrative expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 109,918 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Prepaid licenses and subscriptions </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 57,051 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Prepaid conference expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 21,603 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 29,403 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Prepaid board of directors expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 69,353 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 68,250 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Prepaid rent and security deposit </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 25,004 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 25,004 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Other </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 50,250 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 11,734 </td> </tr> <tr> <td valign="bottom" style="width:69.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total prepaid expenses and other current assets </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,409,929 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 453,478 </td> </tr> </table></div>   <div /></div> </div>

1600000

800000

7809

6857

38684

38634

1.00

0.04

57971

64178

28229

33281

-0.31

-0.21

<div> <div> Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period plus fully vested shares that are subject to issuance for little or no monetary consideration. Diluted earnings per share reflects the potential dilution that could occur if securities or other instruments to issue common stock were exercised or converted into common stock. The following securities are excluded from the calculation of weighted average diluted common shares because their inclusion would have been anti-dilutive:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:25.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Options </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,429,342 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,262,438 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Warrants </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,366,321 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,344,154 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Restricted stock units </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 105,306 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 60,355 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total potentially dilutive shares </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,900,969 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,666,947 </td> </tr> </table></div>   <div /></div> </div>

1150672

570732

P1Y9M18D

3069508

1836782

2300327

1200000

-288600

353452

-568864

-579940

-2000000

-800000

-32623

-291600

189021

251091

3681

5148

1151

23840

1534

1699

3997

3068

4219

12036

17020

82500

18602875

16711541

33906760

28851662

18198377

16365616

0.0125

365814

307291

0.05

5515347

1453386

-93930

-344320

-5917927

-4573846

-5450910

-5351667

953

<div> <div> Recently Adopted Accounting Standards In August 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-13 “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements based on the concepts in the FASB Concepts Statement, including the consideration of costs and benefits. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments are effective for fiscal years beginning after December 15, 2020. The Company adopted ASU 2018-13 effective January 1, 2021. This standard did not have a material impact on the Company’s financial position, results of operations or cash flow. Recently Issued Accounting Standards In February 2016, the FASB issued ASU 2016-02 “Leases (Topic 842)” (“ASU 2016-02”). ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02, as amended, is now effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. The FASB issued ASU 2019-01 “Leases (Topic 842) Codification Improvements” in March 2019 and ASU 2018-10 “Codification Improvements to Topic 842, Leases” and ASU 2018-11 “Leases (Topic 842) Targeted Improvements” in July 2018, and ASU 2018-20 “Leases (Topic 842) - Narrow Scope Improvements for Lessors” in December 2018. ASU 2019-01, ASU 2018-10 and ASU 2018-20 provide certain amendments that affect narrow aspects of the guidance issued in ASU 2016-02. ASU 2018-11 allows all entities adopting ASU 2016-02 to choose an additional (and optional) transition method of adoption, under which an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The Company is currently evaluating ASU 2016-02 and its impact on its financial position, results of operations, and cash flows. In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. The Company is currently evaluating ASU 2019-12 and its impact on its financial position, results of operations, and cash flows. <div /></div> </div>

463353

1091109

627756

463353

97539

783818

627756

156062

5471069

6548053

-5471069

-5348053

<div> <div> Note 1 – Business Organization, Nature of Operations and Basis of Presentation Eyenovia Inc. (“Eyenovia” or the “Company”) is a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its propriety array print (MAPTM) platform technology. Eyenovia aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet®, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. In the clinical trials, the Optejet has demonstrated that Eyenovia’s targeted horizontal microdose delivery can achieve a significantly higher rate of successful ocular topical delivery compared to the established rate reported with traditional eye drops (~ 90% vs. ~ 50%). Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations where there are currently no comparable drug therapies approved by the U.S. Food and Drug Administration (the “FDA”). Eyenovia’s microdose therapeutics follow the FDA-designated pharmaceutical registration and regulatory process. Its products are classified by the FDA as drugs, and not medical devices or drug-device combination products. The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed financial statements of the Company as of March 31, 2021 and for the three months ended March 31, 2021 and 2020. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the operating results for the full year ending December 31, 2021 or any other period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and related disclosures of the Company as of December 31, 2020 and for the year then ended, which were included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 30, 2021. <div /></div> </div>

1627

11734

50250

415795

93930

344320

140521

203799

0.0001

6000000

453478

1409929

110094

863119

7500000

5569136

463353

1530990

573001

396380

707419

<div> <div> Note 8 – Related Party Transactions Lease Agreements The Company’s Vice President of Research and Development and Manufacturing (“VP of R&D”) owns a company that entered into a lease agreement with the Company on September 15, 2016 to lease 953 square feet of space located in Reno, Nevada with respect to its research and development activities. The initial monthly base rent was $3,895 per month over the term of the lease and the security deposit was $3,895. On September 15, 2018, the Company amended the lease agreement to extend it until September 14, 2020 and increase the monthly base rent and security deposit to $4,012.  On September 15, 2020, the Company amended the lease agreement to extend it until September 14, 2022 and increase the monthly base rent and security deposit to $5,404. The Company made $82,500 of leasehold improvements related to this lease which are included on the condensed balance sheet. The Company’s rent expense for this space is recorded in Research and Development on the condensed statement of operations and amounted to $17,020 and $12,036 for the three months ended March 31, 2021 and 2020, respectively. Senju License Agreement During 2015, the Company entered into an Exclusive License Agreement with Senju whereby the Company agreed to grant to Senju an exclusive, royalty-bearing license for its microdose product candidates for Asia to sublicense, develop, make, have made, manufacture, use, import, market, sell, and otherwise distribute the microdose product candidates. In consideration for the license, Senju agreed to pay to Eyenovia five percent (5%) royalties for the term of the license agreement. The agreement will continue in full force and effect, on a country-by-country basis, until the latest to occur of: (i) the tenth (10th) anniversary of the first commercial sale of a microdose product candidate in Asia; or (ii) the expiration of the licensed patents. As of the date of this filing, there had been no commercial sales of a microdose product candidate in Asia, such that no royalties had been earned. Senju is owned by the family of a former member of the Company’s Board of Directors and, together, they beneficially own greater than 5% of the Company’s common stock. On April 8, 2020, Eyenovia entered into an amendment (the "License Amendment") to the Exclusive License Agreement. Pursuant to the License Amendment, the Company can license to any third party the right to research, develop, commercialize, manufacture or use certain products identified below (the "Senju Licensed Products") previously licensed to Senju in China (including the People's Republic of China, Hong Kong, Macao, and Taiwan) and South Korea (the "Territory") if such a license is executed by the Company by April 8, 2021. The Senju Licensed Products are those using piezo-print technology in a microdose dispenser with (i) atropine sulfate as its sole active ingredient to treat myopia in humans and (ii) pilocarpine as its sole active ingredient to treat presbyopia in humans. Pursuant to the License Amendment, the Company must pay Senju (a) close to a mid-double digit percentage of revenue on any lump-sum payments the Company receives from the third party, revenue (net of costs) obtained by the Company from contract research and/or development of the Senju Licensed Product in the Territory, and revenue (net of costs) obtained by the Company from contract manufacture for the device of the Senju Licensed Product in the Territory, the aggregate of which must be at least a high seven figure dollar amount minimum payment to Senju; and (b) a lower-double digit percentage of any sales royalty revenue the Company receives from the third party. Since the Company executed a third-party license  prior to April 8, 2021, the License Amendment will remain in effect for the duration of the license, subject to early termination. The Exclusive License Agreement was further amended in a Letter Agreement by and between the Company and Senju on August 10, 2020 (the “Letter Agreement”). Pursuant to the Letter Agreement, the Company will pay a mid-double digit percentage of certain payments, royalties, or net proceeds received from Arctic Vision in connection with the Arctic Vision License Agreement to Senju. See Note 7 – Commitments and Contingencies – Arctic Vision License Agreement for additional details. <div /></div> </div>

52051

77604

3634287

4247726

-77440919

-82792586

2000000

<div> <div> Revenue Recognition Our revenues are generated primarily through research, development and commercialization agreements. The terms of such agreements may contain multiple promised goods and services, which may include (i) licenses to our intellectual property, and (ii) in certain cases, payment in connection with the manufacturing and delivery of clinical supply materials. Payments to us under these arrangements typically include one or more of the following: non-refundable, upfront license fees; milestone payments; payments for clinical product supply, and royalties on future product sales. We analyze our arrangements to assess whether such arrangements involve joint operating activities. For collaboration arrangements that are deemed to be within the scope of Accounting Standards Codification (“ASC”) Topic 808, “Collaborative Arrangements” (“ASC 808”), we allocate the contract consideration between such joint operating activities and elements that are reflective of a vendor-customer relationship and, therefore, within the scope of ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). Our policy is to recognize amounts allocated to joint operating activities as a reduction in research and development expense. Under ASC 606, we recognize revenue when our customers obtain control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements that we determine are within the scope of ASC 606, we perform the following five steps: <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 1: Identify the contract with the customer;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 2: Identify the performance obligations in the contract;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 3: Determine the transaction price;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 4: Allocate the transaction price to the performance obligations in the contract; and</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 5: Recognize revenue when the company satisfies a performance obligation.</td></tr></table></div> We must make significant judgments in our revenue recognition process, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each performance obligation. In addition, arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered discretionary purchase options. We assess if these options provide a material right to the customer and if so, they are considered performance obligations. For upfront license fees, we must consider how many performance obligations are in the contract and, if more than one, how to allocate the fee to those performance obligations upon satisfaction of the performance obligation(s). Milestone payments represent variable consideration that will be recognized when the performance obligation is achieved. Sales-based royalty payments derived from usage of intellectual property are recognized when those sales occur. During 2020, the Company entered into a license agreement (the “Arctic Vision License Agreement”) with Arctic Vision (Hong Kong) Limited (“Arctic Vision”) and a license agreement (the “Bausch License Agreement”) with Bausch Health Companies, Inc. (“Bausch Health”). Each license has three revenue components: 1) an upfront license fee; 2) milestone payments and 3) royalty payments. See Note 7 – Commitments and Contingencies for additional details. <div /></div> </div>

<div> <div> As of March 31, 2021 and December 31, 2020, accrued expenses and other current liabilities consisted of the following:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> December 31,  </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:12.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accrued research and development expenses </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,119,083 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 348,254 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accrued consulting and professional services </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 18,167 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 235,355 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Credit card payable </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 34,523 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 50,002 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accrued franchise tax </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 13,100 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 32,480 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accrued licensing fees </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 804,447 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accrued interest </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,219 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,068 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Accrued expense reimbursements </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5,459 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Other </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,627 </td> </tr> <tr> <td valign="bottom" style="width:69.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Total accrued expenses and other current liabilities </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,189,092 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,480,692 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> The following securities are excluded from the calculation of weighted average diluted common shares because their inclusion would have been anti-dilutive:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:25.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Options </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,429,342 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,262,438 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Warrants </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,366,321 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,344,154 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Restricted stock units </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 105,306 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 60,355 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total potentially dilutive shares </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,900,969 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,666,947 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> The following table presents information related to stock options as of March 31, 2021:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td colspan="4" valign="bottom" style="width:49.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options Outstanding </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:46.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options Exercisable </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Outstanding </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercisable </td> </tr> <tr> <td colspan="2" valign="bottom" style="width:24.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Remaining Life </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> </tr> <tr> <td colspan="2" valign="bottom" style="width:24.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> In Years </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.24 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 260,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.0 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>260,000 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.95 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 673,544 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.3 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>673,544 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.72 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 764,419 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.74 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.8 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,333 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.89 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 263,500 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.11 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 659,849 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8.4 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>369,646 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.43 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 58,920 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.48 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 45,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.71 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 43,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.00 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 7.6 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,556 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.68 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 25,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8.8 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 9,029 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.10 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 7.4 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.11 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,637 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.19 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 16,500 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.4 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13,750 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.25 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 26,668 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.5 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,668 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.77 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 50,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.20 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 300,387 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.3 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>283,298 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.30 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 60,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.3 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>53,333 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8.72 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 166,918 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.0 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>162,380 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,429,342 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.7 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:11pt;padding-right:3.75pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,862,537 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> A summary of the option activity during the three months ended March 31, 2021 is presented below: <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Remaining </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Aggregate </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Life </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Intrinsic </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> In Years </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding January 1, 2021 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,427,705 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.37 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Granted </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,637 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.11 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding March 31, 2021 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,429,342 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.37 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7.7 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,126,014 </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Exercisable March 31, 2021 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,862,537 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9.5pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.54 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 6.7 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,889,820 </td> </tr> </table></div>   <div /></div> </div>

<div> <div> In applying the Black-Scholes option pricing model to stock options granted, the Company used the following approximate assumptions: <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:36.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> For the Three Months Ended </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:36.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Expected term (years) </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5.85 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5.85 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Risk free interest rate </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.92 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> % </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1.32 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> % </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Expected volatility </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 96 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> % </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 101 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> % </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Expected dividends </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.00 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> % </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.00 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> % </td> </tr> </table></div>   <div /></div> </div>

<div> <div> A summary of the Warrant activity for the three months ended March 31, 2021 is presented below: <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Remaining </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Aggregate </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Life </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Intrinsic </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:07.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> In Years </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding January 1, 2021 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,011,313 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2.43 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Exercised </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (644,992) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2.37 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding March 31, 2021 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,366,321 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2.51 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,530,228 </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Exercisable March 31, 2021 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,366,321 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2.51 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,530,228 </td> </tr> </table></div>   The following table presents information related to Warrants as of March 31, 2021: <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants Outstanding </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:33.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants Exercisable </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Outstanding </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercisable </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Remaining Life </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> In Years </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $2.4696 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,149,941 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,149,941 </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $2.7240 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 216,380 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 216,380 </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,366,321 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,366,321 </td> </tr> </table></div>   <div /></div> </div>

3895

4012

5404

119035

583865

656913

0.0000

P5Y10M6D

1.01

0.96

0.0132

0.0092

3889820

1862537

3.54

P6Y8M12D

1637

7126014

3427705

3429342

3.37

P7Y8M12D

4.13

3.82

5.11

2.72

2.89

3.43

3.48

3.71

4.68

5.11

5.77

5.25

8.72

4.00

3.11

6.20

1.24

5.19

5.10

6.30

2.74

1.95

1862537

9029

26668

162380

1556

369646

283298

260000

13750

5000

53333

4333

673544

3429342

764419

263500

58920

45000

43000

25000

1637

50000

26668

166918

2000

659849

300387

260000

16500

6000

60000

6000

673544

P6Y8M12D

P0Y

P8Y9M18D

P0Y

P5Y6M

P7Y

P7Y7M6D

P8Y4M24D

P7Y3M18D

P4Y

P7Y4M24D

P7Y3M18D

P7Y9M18D

P6Y3M18D

2.4696

2.058

17100726

19776019

24978585

25623577

97539

783818

<div> <div> Note 2 – Summary of Significant Accounting Policies Since the date of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, there have been no material changes to the Company’s significant accounting policies, except as disclosed below. Liquidity and Going Concern As of March 31, 2021, the Company had cash of approximately $24.9 million and an accumulated deficit of approximately $82.8 million. For the three months ended March 31, 2021 and 2020, the Company incurred net losses of approximately $5.4 million and $5.5 million, respectively, and used cash in operations of approximately $4.6 million and $5.9 million, respectively. The Company does not have recurring revenue and has not yet achieved profitability. The Company expects to continue to incur cash outflows from operations. The Company expects that its research and development and general and administrative expenses will continue to increase and, as a result, it will eventually need to generate significant product revenues to achieve profitability. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date that these financial statements are issued. Implementation of the Company’s plans and its ability to continue as a going concern will depend upon the Company’s ability to raise further capital, through the sale of additional equity or debt securities or otherwise, to support its future operations. The Company’s operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The Company’s future capital requirements and the adequacy of its available funds will depend on many factors, including the Company’s ability to successfully commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement its product and service offerings. If the Company is unable to secure additional capital, it may be required to curtail its research and development initiatives and take additional measures to reduce costs in order to conserve its cash. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents in the financial statements. The Company has cash deposits in a financial institution which, at times, may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company has not experienced losses in such accounts and periodically evaluates the creditworthiness of its financial institutions. As of March 31, 2021 and December 31, 2020, the Company had cash balances in excess of FDIC insurance limits of  $24,657,048 and $28,121,828, respectively.  Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period plus fully vested shares that are subject to issuance for little or no monetary consideration. Diluted earnings per share reflects the potential dilution that could occur if securities or other instruments to issue common stock were exercised or converted into common stock. The following securities are excluded from the calculation of weighted average diluted common shares because their inclusion would have been anti-dilutive:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:25.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Options </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,429,342 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,262,438 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Warrants </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,366,321 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,344,154 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Restricted stock units </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 105,306 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 60,355 </td> </tr> <tr> <td valign="bottom" style="width:72.44%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Total potentially dilutive shares </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4,900,969 </td> <td valign="bottom" style="width:02.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:11.72%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 5,666,947 </td> </tr> </table></div>   Revenue Recognition Our revenues are generated primarily through research, development and commercialization agreements. The terms of such agreements may contain multiple promised goods and services, which may include (i) licenses to our intellectual property, and (ii) in certain cases, payment in connection with the manufacturing and delivery of clinical supply materials. Payments to us under these arrangements typically include one or more of the following: non-refundable, upfront license fees; milestone payments; payments for clinical product supply, and royalties on future product sales. We analyze our arrangements to assess whether such arrangements involve joint operating activities. For collaboration arrangements that are deemed to be within the scope of Accounting Standards Codification (“ASC”) Topic 808, “Collaborative Arrangements” (“ASC 808”), we allocate the contract consideration between such joint operating activities and elements that are reflective of a vendor-customer relationship and, therefore, within the scope of ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). Our policy is to recognize amounts allocated to joint operating activities as a reduction in research and development expense. Under ASC 606, we recognize revenue when our customers obtain control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements that we determine are within the scope of ASC 606, we perform the following five steps: <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 1: Identify the contract with the customer;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 2: Identify the performance obligations in the contract;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 3: Determine the transaction price;</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 4: Allocate the transaction price to the performance obligations in the contract; and</td></tr></table></div> <div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"></td><td valign="top" align="left" style="width: 17.00pt;"> · </td><td style="width:1pt;"></td><td align="left" valign="top"> Step 5: Recognize revenue when the company satisfies a performance obligation.</td></tr></table></div> We must make significant judgments in our revenue recognition process, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each performance obligation. In addition, arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered discretionary purchase options. We assess if these options provide a material right to the customer and if so, they are considered performance obligations. For upfront license fees, we must consider how many performance obligations are in the contract and, if more than one, how to allocate the fee to those performance obligations upon satisfaction of the performance obligation(s). Milestone payments represent variable consideration that will be recognized when the performance obligation is achieved. Sales-based royalty payments derived from usage of intellectual property are recognized when those sales occur. During 2020, the Company entered into a license agreement (the “Arctic Vision License Agreement”) with Arctic Vision (Hong Kong) Limited (“Arctic Vision”) and a license agreement (the “Bausch License Agreement”) with Bausch Health Companies, Inc. (“Bausch Health”). Each license has three revenue components: 1) an upfront license fee; 2) milestone payments and 3) royalty payments. See Note 7 – Commitments and Contingencies for additional details. Deferred License Fee The Company enters into license agreements which provide for the receipt of non-refundable, upfront licensing payments. These payments are recorded as deferred license fees and will be earned and recognized as revenue upon the satisfaction of performance obligations. See Note 7 – Commitments and Contingencies for additional details. Deferred License Costs The Company enters into license agreements which provide for payment of license costs in connection with the Company’s receipt of license fees. These payments are recorded as deferred license costs and will be recorded as an expense when the related license fee revenue is recognized. See Note 8 – Related Party Transactions for additional details. Recently Adopted Accounting Standards In August 2018, the FASB issued Accounting Standards Update (“ASU”) No. 2018-13 “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). The amendments in ASU 2018-13 modify the disclosure requirements on fair value measurements based on the concepts in the FASB Concepts Statement, including the consideration of costs and benefits. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. The amendments are effective for fiscal years beginning after December 15, 2020. The Company adopted ASU 2018-13 effective January 1, 2021. This standard did not have a material impact on the Company’s financial position, results of operations or cash flow. Recently Issued Accounting Standards In February 2016, the FASB issued ASU 2016-02 “Leases (Topic 842)” (“ASU 2016-02”). ASU 2016-02 requires that a lessee recognize the assets and liabilities that arise from operating leases. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. In transition, lessees and lessors are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. ASU 2016-02, as amended, is now effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. The FASB issued ASU 2019-01 “Leases (Topic 842) Codification Improvements” in March 2019 and ASU 2018-10 “Codification Improvements to Topic 842, Leases” and ASU 2018-11 “Leases (Topic 842) Targeted Improvements” in July 2018, and ASU 2018-20 “Leases (Topic 842) - Narrow Scope Improvements for Lessors” in December 2018. ASU 2019-01, ASU 2018-10 and ASU 2018-20 provide certain amendments that affect narrow aspects of the guidance issued in ASU 2016-02. ASU 2018-11 allows all entities adopting ASU 2016-02 to choose an additional (and optional) transition method of adoption, under which an entity initially applies the new leases standard at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The Company is currently evaluating ASU 2016-02 and its impact on its financial position, results of operations, and cash flows. In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for fiscal years beginning after December 15, 2021. The Company is currently evaluating ASU 2019-12 and its impact on its financial position, results of operations, and cash flows. <div /></div> </div>

11740607

69409949

1710

-57671052

12325304

75445289

1977

-63121962

15303885

92742306

2498

-77440919

12140121

94930144

2563

-82792586

<div> <div> Note 9 – Stockholders’ Equity Securities Purchase Agreement On March 24, 2020, the Company closed on a private placement of approximately $6.0 million of Units. Each Unit consists of (i) one share of the Company’s common stock, (ii) a one-year warrant to purchase 0.5 of a share of common stock (“Class A Warrant”), and (iii) a five-year warrant to purchase 0.75 of a share of common stock (“Class B Warrant”) (collectively, the Class A Warrants and Class B Warrants, the “Warrants”). The Units were sold to the public at a price of $2.21425 per Unit and to certain directors and executive officers at a price of $2.42625 per Unit. The Company generated approximately $5.3 million of net proceeds in the offering after deducting placement agent fees and offering expenses. In the offering, the Company issued an aggregate of 2,675,293 shares of common stock, Class A Warrants to purchase up to 1,337,659 shares of common stock, and Class B Warrants to purchase up to 2,006,495 shares of common stock. The exercise price of the Class A Warrants issued to the public is $2.058 per share and the exercise price of the Class A Warrants issued to the directors and officers is $2.27 per share. The exercise price of the Class B Warrants issued to the public is $2.4696 per share and the exercise price of the Class B Warrants issued to the directors and officers is $2.724 per share. In connection with the private placement, on March 23, 2020, the Company also entered into a Registration Rights Agreement with the investors. Pursuant to the Registration Rights Agreement, the Company must file with the SEC, no later than 30 days following the date on which the Company files its Form 10-K for the year ended December 31, 2019 with the SEC, a registration statement on Form S-3 covering the shares of common stock issued in the offering and the shares of common stock underlying the Warrants. The Company timely filed the registration statement on Form S-3 (Registration Statement No. 333-237790), which was declared and has remained effective with the SEC since May 13, 2020. Stock Options In applying the Black-Scholes option pricing model to stock options granted, the Company used the following approximate assumptions: <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:36.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> For the Three Months Ended </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:36.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> March 31,  </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2021 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> 2020 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Expected term (years) </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5.85 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 5.85 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Risk free interest rate </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.92 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> % </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1.32 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> % </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Expected volatility </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 96 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> % </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 101 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> % </td> </tr> <tr> <td valign="bottom" style="width:61.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Expected dividends </td> <td valign="bottom" style="width:17.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.00 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> % </td> <td valign="bottom" style="width:17.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 0.00 </td> <td valign="bottom" style="width:02.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> % </td> </tr> </table></div>   The Company has computed the fair value of stock options granted using the Black-Scholes option pricing model. Option forfeitures are accounted for at the time of occurrence. The expected term is the estimated period of time that options granted are expected to be outstanding. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee option grants. The Company does not yet have a trading history to support its historical volatility calculations. Accordingly, the Company is utilizing an expected volatility figure based on a review of the historical volatility of comparable entities over a period of time equivalent to the expected life of the instrument being valued. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued. The weighted average estimated grant date fair value of the stock options granted for the three months ended March 31, 2021 and 2020 was approximately $3.82 and $4.13 per share, respectively. A summary of the option activity during the three months ended March 31, 2021 is presented below: <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Remaining </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Aggregate </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Life </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Intrinsic </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> In Years </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding January 1, 2021 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,427,705 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.37 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Granted </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 1,637 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.11 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding March 31, 2021 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,429,342 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.37 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7.7 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 7,126,014 </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:36.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Exercisable March 31, 2021 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,862,537 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:9.5pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.54 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:13.18%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 6.7 </td> <td valign="bottom" style="width:02.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:13.14%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,889,820 </td> </tr> </table></div>   The following table presents information related to stock options as of March 31, 2021:   <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;"> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td colspan="4" valign="bottom" style="width:49.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options Outstanding </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="3" valign="bottom" style="width:46.90%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options Exercisable </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Outstanding </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercisable </td> </tr> <tr> <td colspan="2" valign="bottom" style="width:24.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Remaining Life </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> </tr> <tr> <td colspan="2" valign="bottom" style="width:24.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> In Years </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Options </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.24 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 260,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.0 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>260,000 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.95 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 673,544 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.3 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>673,544 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.72 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 764,419 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.74 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.8 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,333 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.89 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 263,500 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.11 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 659,849 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8.4 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>369,646 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.43 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 58,920 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.48 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 45,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3.71 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 43,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.00 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 7.6 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,556 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.68 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 25,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 8.8 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 9,029 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.10 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 6,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 7.4 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,000 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.11 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,637 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.19 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 16,500 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.4 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13,750 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.25 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 26,668 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.5 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>26,668 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5.77 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 50,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">  — </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.20 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 300,387 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.3 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>283,298 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.30 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 60,000 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.3 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>53,333 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8.72 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 166,918 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7.0 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>162,380 </td> </tr> <tr> <td valign="bottom" style="width:02.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 3,429,342 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.62%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:10pt;padding-right:3pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.7 </td> <td valign="bottom" style="width:03.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:21.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;color:#000000;font-family:Times New Roman,Times,serif;font-size:11pt;padding-right:3.75pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,862,537 </td> </tr> </table></div>   Warrants A summary of the Warrant activity for the three months ended March 31, 2021 is presented below: <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Remaining </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Aggregate </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:07.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Life </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Intrinsic </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:07.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> In Years </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td colspan="2" valign="bottom" style="width:10.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Value </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding January 1, 2021 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2,011,313 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2.43 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Exercised </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> (644,992) </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2.37 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">    </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Outstanding March 31, 2021 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,366,321 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2.51 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,530,228 </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:57.98%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> Exercisable March 31, 2021 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,366,321 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:06.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 2.51 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 3,530,228 </td> </tr> </table></div>   The following table presents information related to Warrants as of March 31, 2021: <div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;"> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants Outstanding </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:33.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants Exercisable </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Weighted </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Outstanding </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Average </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercisable </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Exercise </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Remaining Life </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Number of </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Price </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> In Years </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">      </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;"> Warrants </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> $2.4696 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,149,941 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,149,941 </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> $2.7240 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 216,380 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 216,380 </td> </tr> <tr> <td valign="bottom" style="width:65.36%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,366,321 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:10.96%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 4.0 </td> <td valign="bottom" style="width:01.64%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:09.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"> 1,366,321 </td> </tr> </table></div>   Stock-Based Compensation Expense The Company recorded stock-based compensation expense related to stock options and restricted stock units of $656,913 ($329,713 of which was included within research and development expenses and $327,200 was included within general and administrative expenses on the condensed statements of operations) and $583,865 ($307,409 of which was included within research and development expenses and $276,456 was included within general and administrative expenses on the condensed statements of operations) during the three months ended March 31, 2021 and 2020, respectively. As of March 31, 2021, there was $3,069,508 of unrecognized stock-based compensation expense which the Company expects to recognize over a weighted average period of 1.8 years. <div /></div> </div>

2675293

2006495

1337659

6000000

<div> <div> Note 11 – Subsequent Events Stock Warrant Exercises Subsequent to March 31, 2021, the Company issued an aggregate of 232,022 shares of common stock pursuant to the exercise of warrants for aggregate proceeds of $573,001 at an exercise prices of  $2.4696. Loan and Security Agreement On May 7, 2021, the Company entered into a Loan and Security Agreement (the “Loan”) with Silicon Valley Bank (the “Lender”) for an aggregate principal amount of up to $25.0 million. The Loan bears interest at annual rate equal to the greater of (a) the sum of 1.25% plus the prime rate as reported in The Wall Street Journal and (b) 5.00%. The Loan matures on May 1, 2025. The initial tranche in the amount of $7.5 million was received by the Company on May 7, 2021. In connection with the Loan, the Company issued to the Lender warrants to purchase 91,884 shares of common stock at an exercise price per share equal to $4.76. The warrants are exercisable for a period of ten years from the date of issuance. At the Company’s option, Eyenovia has the ability to draw down the remaining $17.5 million in gross proceeds in two tranches over the next two years based upon the achievement of several milestones in accordance with the terms of the agreement. <div /></div> </div>

17308804

25330563

1150672

570732

Includes gross proceeds of $5,984,931, less total issuance costs of $533,189. Includes $203,799 of leasehold improvements and $140,521 of equipment purchases for the three months ended March 31, 2021. Includes gross proceeds of $5,984,931, less issuance costs of $415,795 deducted directly from the private placement proceeds.

EX-101.SCH 7 eyen-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Condensed Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Accrued Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Notes Payable - Schedule of notes payable (Details) link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Condensed Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - Condensed Statements of Changes in Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00405 - Statement - Condensed Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - Business Organization, Nature of Operations and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Significant Accounting Policies - Anti-dilutive weighted average diluted common shares (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Notes Payable - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Stockholders' Equity - Black Scholes option (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - Stockholders' Equity - Summary of option activity (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - Stockholders' Equity - Additional information related to Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40905 - Disclosure - Stockholders' Equity - Summary of information related to stock options (Details) link:presentationLink link:calculationLink link:definitionLink 40906 - Disclosure - Stockholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Employee Benefit Plans (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Business Organization, Nature of Operations and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Accrued Compensation link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Employee Benefit Plans link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Accrued Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 40904 - Disclosure - Stockholders' Equity - Warrants Activity (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 eyen-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 eyen-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 eyen-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information Document Type Document Period End Date Entity Registrant Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Trading Symbol Entity Shell Company Title of 12(b) Security Security Exchange Name Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Condensed Balance Sheets Statement [Table] Statement [Line Items] Stock options Stock option activity Assets [Abstract] Assets Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Deferred Costs, Current Deferred license costs Amount of license fee and expense reimbursements receivables classified as current. License Fee and Expense Reimbursements Receivables License fee and expense reimbursements receivables Prepaid Expense and Other Assets, Current Total prepaid expenses and other current assets Prepaid expenses and other current assets Assets, Current Total Current Assets Property, Plant and Equipment, Net Property and equipment, net Security Deposit Security deposit Assets Total Assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Current [Abstract] Current Liabilities: Accounts Payable, Current Accounts payable Workers' Compensation Liability, Current Accrued compensation Carrying value as of the balance sheet date of obligations incurred and payable, of accrued expenses and other current liabilities. Accrued expenses and other liabilities, Current Accrued expenses and other current liabilities Deferred Rent Credit, Current Deferred rent - current portion Contract with Customer, Liability, Current Deferred license fee Short-term Bank Loans and Notes Payable Notes payable - current portion Liabilities, Current Total Current Liabilities Deferred Rent Credit, Noncurrent Deferred rent - non-current portion Notes Payable, Noncurrent Notes payable - non-current portion Non-Current Portion Liabilities Total Liabilities Commitments and Contingencies. Commitments and contingencies (Note 7) Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Equity: Preferred Stock, Value, Issued Preferred stock, $0.0001 par value, 6,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively Common Stock, Value, Issued Common stock, $0.0001 par value, 90,000,000 shares authorized; 25,623,577 and 24,978,585 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Balance Balance Total Stockholders' Equity Liabilities and Equity Total Liabilities and Stockholders' Equity Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Condensed Statements of Operations Revenues [Abstract] Operating Income Revenue from Contract with Customer, Excluding Assessed Tax Revenue Cost of Revenue Cost of revenue Gross Profit Gross Profit Operating Expenses [Abstract] Operating Expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total Operating Expenses Operating Income (Loss) Loss From Operations Nonoperating Income (Expense) [Abstract] Other Income (Expense): Interest Expense Interest expense Interest Income (Expense), Nonoperating, Net Interest income Net Income (Loss) Attributable to Parent Net loss Net Loss Net loss Earnings Per Share, Basic and Diluted [Abstract] Net Loss Per Share Earnings Per Share, Basic and Diluted - Basic and Diluted Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Weighted Average Number of Common Shares Outstanding Weighted Average Number of Shares Outstanding, Basic and Diluted - Basic and Diluted Condensed Statements of Changes in Stockholders' Equity Shares, Outstanding Balance (in shares) Balance (in shares) Stock issuance of common stock two value on public offering. Stock Issued During Period Value New Issues Two Issuance of common stock and warrants in private placement Stock issuance of common stock one shares on public offering Stock Issued During Period Shares New Issues Two Issuance of common stock and warrants in private placement(in shares) Value of stock issued as a result of the exercise of warrants. Stock Issued During Period, Value, Warrants Exercised Exercise of stock warrants Number of shares issued as a result of the exercise of warrants. Stock Issued During Period, Shares, Warrants Exercised Exercise of stock warrants (in shares) Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock One Common Stock One [Member] Common Stock One [Member] It represents issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. Proceeds Of Stock Issued During Period Gross Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Condensed Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows From Operating Activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Depletion and Amortization Depreciation of property and equipment Share-based Compensation Stock-based compensation Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets The increase (decrease) during the reporting period in the amount of license fee and expense reimbursements receivables. Increase Decrease In License Fee And Expense Reimbursements Receivables License fee and expense reimbursements receivables Increase (Decrease) in Deferred Charges Deferred license costs Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued compensation Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Accrued expenses and other current liabilities Increase (Decrease) in Contract with Customer, Liability Deferred license fee Amount of increase (decrease) of deferred rent that provides economic benefits in future periods. Increase Decrease in Deferred Rent Deferred rent Net Cash Provided by (Used in) Operating Activities Cash used in operations Net Cash Used In Operating Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash Flows From Investing Activities Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Purchases Net Cash Provided by (Used in) Investing Activities Net Cash Used In Investing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash Flows From Financing Activities Proceeds from sale of common stock and warrants in private placement Proceeds from Warrant Exercises Proceeds from exercise of stock warrants Proceeds from exercise of warrants Repayments of Notes Payable Repayments of notes payable Repayments of loan The cash outflow associated with the repurchase of amount received from entity's offering of stock to the public. Payments for Repurchase of Public Offering Payment of offering issuance costs Net Cash Provided by (Used in) Financing Activities Net Cash Provided By Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net Decrease in Cash and Cash Equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents - End of Period Cash and cash equivalents - Beginning of Period Supplemental Cash Flow Information [Abstract] Supplemental Disclosure of Cash Flow Information: Interest Paid, Capitalized, Investing Activities Interest Noncash Investing and Financing Items [Abstract] Supplemental Disclosure of Non-Cash Investing and Financing Activities The amount of accrual of private placement offering costs. Accrual Of Private Placement Offering Costs Accrual of private placement offering costs The amount of purchase of insurance premium financed by short term notes payable. Purchase Of Insurance Premium Financed By Short Term Note Payable Purchase of insurance premium financed by note payable Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Payments of Debt Issuance Costs Business Organization, Nature of Operations and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Business Organization, Nature of Operations and Basis of Presentation Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Prepaid Expenses and Other Current Assets The entire disclosure of prepaid expenses and other current assets. Prepaid Expenses and Other Current Assets Disclosure [Text Block] Prepaid Expenses and Other Current Assets Accrued Compensation Compensation Related Costs, General [Text Block] Accrued Compensation Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Expenses and Other Current Liabilities Notes Payable The entire disclosure of notes payable. Notes Payable Disclosure [Text Block] Notes Payable Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Related Party Transactions Related Party Transactions Disclosure [Text Block] Related Party Transactions Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Stockholders' Equity Employee Benefit Plans Compensation and Employee Benefit Plans [Text Block] Employee Benefit Plans Subsequent Events Subsequent Events [Text Block] Subsequent Events Disclosure of accounting policy for liquidity and going concern. Liquidity and Going Concern [Text Block] Liquidity and Going Concern Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Earnings Per Share, Policy [Policy Text Block] Net Loss Per Common Share Revenue from Contract with Customer [Policy Text Block] Revenue Recognition Disclosure of accounting policy for deferral license fee. Deferred License Fee [Policy Text Block] Deferred License Fee Disclosure of accounting policy for deferral license costs. Deferred License Costs [Policy Text Block] Deferred License Costs New Accounting Pronouncements, Policy [Policy Text Block] Recently Adopted Accounting Standards Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of anti-dilutive weighted average diluted common shares Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of prepaid expenses and other current assets Tabular disclosure of accrued compensation. Disclosure of Accrued compensation [Table Text Block] Schedule of accrued compensation Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses and other current liabilities Tabular disclosure of notes payable. Schedule of Notes Payable [Table Text Block] Schedule of notes payable Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Black-Scholes option pricing model to stock options granted Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of the stock option activity Schedule Of Share Based Compensation Shares Outstanding Under Stock Option Plans By Exercise Price Range Table Text Block Schedule of information related to stock options Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Summary of the Warrant activity and related information This refers percentage of success rate. Percentage Of Success Rate Of Optejet This represents successful percentage rate. Percentage of Successful Rate of Traditional Eye Drops Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total potentially dilutive shares Cash, Uninsured Amount Amount of upfront payments received by the entity, pursuant to a license agreement. License Agreements, Upfront Payments Received Upfront payment received Upfront payment received Maximum amount of additional payments receivable by the company pursuant to a license agreement. License Agreements, Maximum Additional Payments Receivable Maximum additional payments receivable Amount of Payroll Taxes Receivable. Payroll Taxes Receivable Payroll tax receivable Prepaid Insurance Prepaid insurance expenses Represents the information pertaining to Prepaid general and administrative expenses. Prepaid general and administrative expenses Prepaid general and administrative expenses The amount of prepaid licenses and subscriptions, current. Prepaid Licenses and Subscriptions Prepaid licenses and subscriptions Amount of assets related to prepaid conference expenses. Prepaid conference Expenses Prepaid conference expenses Carrying value as of the balance sheet date of director fees prepaid, classified as current. Prepaid Director Fees, Current Prepaid board of director expenses Amount of asset related to consideration paid in advance for rent and security deposits that provides economic benefits within a future period of one year or the normal operating cycle. Prepaid Rent and Security Deposit Prepaid rent and security deposit Other Assets Other Accrued Bonuses, Current Accrued bonus expenses Accrued Salaries, Current Accrued payroll expenses Employee-related Liabilities, Current Total accrued compensation Amount of accrued research and development expenses paid by the entity. Accrued research and development expenses, Current Accrued research and development expenses Carrying value as of the balance sheet date of obligations incurred through that date and payable for consulting and professional service, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Consulting and Professional Services, Current Accrued consulting and professional services Amount of credit card expenses payable by the entity. Credit Card payable Credit card payable Amount of accrued franchise tax expenses paid by the entity. Accrued Franchise Tax Accrued franchise tax The amount of accrued licensing fees, current. Accrued Licensing Fees Accrued licensing fees Interest Payable, Current Accrued interest Carrying value as of the balance sheet date of obligations incurred through that date and payable for expense reimbursements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Expense Reimbursements Accrued expense reimbursements Other Accrued Liabilities, Current Other Accrued Liabilities and Other Liabilities Total accrued expenses and other current liabilities Notes Payable, Current Current Portion Notes Payable. Total Schedule of Short-term Debt [Table] Short-term Debt [Line Items] Notes Payable Number of monthly payments. Number Of Monthly Payments Number of monthly payments EX-101.PRE 11 eyen-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2021	May 12, 2021
Document and Entity Information
Document Type	10-Q
Document Period End Date	Mar. 31, 2021
Entity Registrant Name	EYENOVIA, INC.
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Trading Symbol	EYEN
Entity Shell Company	false
Title of 12(b) Security	Common Stock, $0.0001 Par Value
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		25,855,599
Entity Central Index Key	0001682639
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 24,907,048	$ 28,371,828
Deferred license costs	800,000	1,600,000
License fee and expense reimbursements receivables	908,231	2,966,039
Prepaid expenses and other current assets	1,409,929	453,478
Total Current Assets	28,025,208	33,391,345
Property and equipment, net	707,419	396,380
Security deposit	119,035	119,035
Total Assets	28,851,662	33,906,760
Current Liabilities:
Accounts payable	1,815,117	1,461,665
Accrued compensation	570,732	1,150,672
Accrued expenses and other current liabilities	1,189,092	1,480,692
Deferred rent - current portion	6,857	7,809
Deferred license fee	12,000,000	14,000,000
Notes payable - current portion	783,818	97,539
Total Current Liabilities	16,365,616	18,198,377
Deferred rent - non-current portion	38,634	38,684
Notes payable - non-current portion	307,291	365,814
Total Liabilities	16,711,541	18,602,875
Commitments and contingencies (Note 7)
Stockholders' Equity:
Preferred stock, $0.0001 par value, 6,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	0	0
Common stock, $0.0001 par value, 90,000,000 shares authorized; 25,623,577 and 24,978,585 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively	2,563	2,498
Additional paid-in capital	94,930,144	92,742,306
Accumulated deficit	(82,792,586)	(77,440,919)
Total Stockholders' Equity	12,140,121	15,303,885
Total Liabilities and Stockholders' Equity	$ 28,851,662	$ 33,906,760

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Condensed Balance Sheets
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	6,000,000	6,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	90,000,000	90,000,000
Common Stock, Shares, Issued	25,623,577	24,978,585
Common Stock, Shares, Outstanding	25,623,577	24,978,585

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Statements of Operations - USD ($)	3 Months Ended
Condensed Statements of Operations - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Operating Income
Revenue	$ 2,000,000
Cost of revenue	(800,000)
Gross Profit	1,200,000
Operating Expenses:
Research and development	4,247,726	$ 3,634,287
General and administrative	2,300,327	1,836,782
Total Operating Expenses	6,548,053	5,471,069
Loss From Operations	(5,348,053)	(5,471,069)
Other Income (Expense):
Interest expense	(5,148)	(3,681)
Interest income	1,534	23,840
Net Loss	$ (5,351,667)	$ (5,450,910)
Net Loss Per Share
- Basic and Diluted	$ (0.21)	$ (0.31)
Weighted Average Number of Common Shares Outstanding
- Basic and Diluted	25,330,563	17,308,804

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Statements of Changes in Stockholders' Equity - USD ($)

Common Stock

Additional Paid-In Capital

Accumulated Deficit

Total

Balance at Dec. 31, 2019

$ 1,710

$ 69,409,949

$ (57,671,052)

$ 11,740,607

Balance (in shares) at Dec. 31, 2019

17,100,726

Issuance of common stock and warrants in private placement

^[1]

$ 267

5,451,475

5,451,742

Issuance of common stock and warrants in private placement(in shares)

^[1]

2,675,293

Stock-based compensation

$ 0

583,865

Net loss

(5,450,910)

Balance at Mar. 31, 2020

$ 1,977

75,445,289

(63,121,962)

12,325,304

Balance (in shares) at Mar. 31, 2020

19,776,019

Balance at Dec. 31, 2020

$ 2,498

92,742,306

(77,440,919)

15,303,885

Balance (in shares) at Dec. 31, 2020

24,978,585

Exercise of stock warrants

$ 65

1,530,925

1,530,990

Exercise of stock warrants (in shares)

644,992

Stock-based compensation

$ 0

656,913

Net loss

(5,351,667)

Balance at Mar. 31, 2021

$ 2,563

$ 94,930,144

$ (82,792,586)

$ 12,140,121

Balance (in shares) at Mar. 31, 2021

25,623,577

[1]	Includes gross proceeds of $5,984,931, less total issuance costs of $533,189.

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Statements of Changes in Stockholders' Equity (Parenthetical) - Common Stock One [Member]	3 Months Ended
	Mar. 31, 2020 USD ($)
Proceeds Of Stock Issued During Period Gross	$ 5,984,931
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	$ 533,189

XML 18 R7.htm IDEA: XBRL DOCUMENT

Condensed Statements of Cash Flows - USD ($)

3 Months Ended

Mar. 31, 2021

Mar. 31, 2020

Cash Flows From Operating Activities

Net loss

$ (5,351,667)

$ (5,450,910)

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation of property and equipment

33,281

28,229

Stock-based compensation

656,913

583,865

Changes in operating assets and liabilities:

Prepaid expenses and other current assets

(251,091)

(189,021)

License fee and expense reimbursements receivables

2,057,808

Deferred license costs

800,000

Accounts payable

353,452

(288,600)

Accrued compensation

(579,940)

(568,864)

Accrued expenses and other current liabilities

(291,600)

(32,623)

Deferred license fee

(2,000,000)

Deferred rent

(1,002)

(3)

Net Cash Used In Operating Activities

(4,573,846)

(5,917,927)

Cash Flows From Investing Activities

Purchases of property and equipment

^[1]

(344,320)

(93,930)

Net Cash Used In Investing Activities

(344,320)

(93,930)

Cash Flows From Financing Activities

Proceeds from sale of common stock and warrants in private placement

^[2]

5,569,136

Proceeds from exercise of stock warrants

1,530,990

Repayments of notes payable

(77,604)

(52,051)

Payment of offering issuance costs

(1,738)

Net Cash Provided By Financing Activities

1,453,386

5,515,347

Net Decrease in Cash and Cash Equivalents

(3,464,780)

(496,510)

Cash and cash equivalents - Beginning of Period

28,371,828

14,152,601

Cash and cash equivalents - End of Period

24,907,048

13,656,091

Supplemental Disclosure of Cash Flow Information:

Interest

3,997

1,699

Supplemental Disclosure of Non-Cash Investing and Financing Activities

Accrual of private placement offering costs

115,656

Purchase of insurance premium financed by note payable

$ 705,360

$ 475,216

[1]	Includes $203,799 of leasehold improvements and $140,521 of equipment purchases for the three months ended March 31, 2021.
[2]	Includes gross proceeds of $5,984,931, less issuance costs of $415,795 deducted directly from the private placement proceeds.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Condensed Statements of Cash Flows (Parenthetical) - USD ($)

3 Months Ended

Mar. 31, 2021

Mar. 31, 2020

Purchases

^[1]

$ 344,320

$ 93,930

Leasehold improvements

Purchases

203,799

Equipment purchases

Purchases

$ 140,521

Common Stock One [Member]

Proceeds Of Stock Issued During Period Gross

5,984,931

Payments of Debt Issuance Costs

$ 415,795

[1]	Includes $203,799 of leasehold improvements and $140,521 of equipment purchases for the three months ended March 31, 2021.

XML 20 R9.htm IDEA: XBRL DOCUMENT

Business Organization, Nature of Operations and Basis of Presentation	3 Months Ended
	Mar. 31, 2021
Business Organization, Nature of Operations and Basis of Presentation
Business Organization, Nature of Operations and Basis of Presentation	Note 1 – Business Organization, Nature of Operations and Basis of Presentation Eyenovia Inc. (“Eyenovia” or the “Company”) is a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its propriety array print (MAPTM) platform technology. Eyenovia aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet®, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. In the clinical trials, the Optejet has demonstrated that Eyenovia’s targeted horizontal microdose delivery can achieve a significantly higher rate of successful ocular topical delivery compared to the established rate reported with traditional eye drops (~ 90% vs. ~ 50%). Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations where there are currently no comparable drug therapies approved by the U.S. Food and Drug Administration (the “FDA”). Eyenovia’s microdose therapeutics follow the FDA-designated pharmaceutical registration and regulatory process. Its products are classified by the FDA as drugs, and not medical devices or drug-device combination products. The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the condensed financial statements of the Company as of March 31, 2021 and for the three months ended March 31, 2021 and 2020. The results of operations for the three months ended March 31, 2021 are not necessarily indicative of the operating results for the full year ending December 31, 2021 or any other period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and related disclosures of the Company as of December 31, 2020 and for the year then ended, which were included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 30, 2021.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2021

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

Liquidity and Going Concern

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents in the financial statements.

Net Loss Per Common Share

The following securities are excluded from the calculation of weighted average diluted common shares because their inclusion would have been anti-dilutive:


	March 31,
	2021	2020
Options	3,429,342	2,262,438
Warrants	1,366,321	3,344,154
Restricted stock units	105,306	60,355
Total potentially dilutive shares	4,900,969	5,666,947

Revenue Recognition

Step 1: Identify the contract with the customer;

Step 2: Identify the performance obligations in the contract;

Step 3: Determine the transaction price;

Step 4: Allocate the transaction price to the performance obligations in the contract; and

Step 5: Recognize revenue when the company satisfies a performance obligation.

During 2020, the Company entered into a license agreement (the “Arctic Vision License Agreement”) with Arctic Vision (Hong Kong) Limited (“Arctic Vision”) and a license agreement (the “Bausch License Agreement”) with Bausch Health Companies, Inc. (“Bausch Health”). Each license has three revenue components: 1) an upfront license fee; 2) milestone payments and 3) royalty payments. See Note 7 – Commitments and Contingencies for additional details.

Deferred License Fee

Deferred License Costs

Recently Adopted Accounting Standards

Recently Issued Accounting Standards

XML 22 R11.htm IDEA: XBRL DOCUMENT

Prepaid Expenses and Other Current Assets

3 Months Ended

Mar. 31, 2021

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

Note 3 – Prepaid Expenses and Other Current Assets

As of March 31, 2021 and December 31, 2020, prepaid expenses and other current assets consisted of the following:


	March 31,			December 31,
	2021		2020
Payroll tax receivable	$	270,682	$	151,942
Prepaid insurance expenses		863,119		110,094
Prepaid general and administrative expenses		109,918		—
Prepaid licenses and subscriptions		—		57,051
Prepaid conference expenses		21,603		29,403
Prepaid board of directors expenses		69,353		68,250
Prepaid rent and security deposit		25,004		25,004
Other		50,250		11,734
Total prepaid expenses and other current assets	$	1,409,929	$	453,478

XML 23 R12.htm IDEA: XBRL DOCUMENT

Accrued Compensation

3 Months Ended

Mar. 31, 2021

Accrued Compensation

Accrued Compensation

Note 4 – Accrued Compensation

As of March 31, 2021 and December 31, 2020, accrued compensation consisted of the following:


	March 31,		December 31,
	2021		2020
Accrued bonus expenses	$	284,698	$	938,873
Accrued payroll expenses		286,034		211,799
Total accrued compensation	$	570,732	$	1,150,672

XML 24 R13.htm IDEA: XBRL DOCUMENT

Accrued Expenses and Other Current Liabilities

3 Months Ended

Mar. 31, 2021

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Note 5 – Accrued Expenses and Other Current Liabilities

As of March 31, 2021 and December 31, 2020, accrued expenses and other current liabilities consisted of the following:


	March 31,		December 31,
	2021		2020
Accrued research and development expenses	$	1,119,083	$	348,254
Accrued consulting and professional services		18,167		235,355
Credit card payable		34,523		50,002
Accrued franchise tax		13,100		32,480
Accrued licensing fees		—		804,447
Accrued interest		4,219		3,068
Accrued expense reimbursements		—		5,459
Other		—		1,627
Total accrued expenses and other current liabilities	$	1,189,092	$	1,480,692

XML 25 R14.htm IDEA: XBRL DOCUMENT

Notes Payable

3 Months Ended

Mar. 31, 2021

Notes Payable

Notes Payable

Note 6 – Notes Payable

As of March 31, 2021 and December 31, 2020, notes payable consisted of the following:


	March 31,						December 31,
	2021						2020
			Non-						Non-
	Current		Current				Current		Current
	Portion		Portion		Total		Portion		Portion		Total
BankDirect Capital Finance loan	$	627,756	$	—	$	627,756	$	—	$	—	$	—
Paycheck Protection Program loan		156,062		307,291		463,353		97,539		365,814		463,353
Total	$	783,818	$	307,291	$	1,091,109	$	97,539	$	365,814	$	463,353

XML 26 R15.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2021
Commitments and Contingencies
Commitments and Contingencies	Note 7 – Commitments and Contingencies See Note 8 - Related Party Transactions for certain commitments and contingencies entered into with certain related parties. Litigations, Claims and Assessments The Company may be involved in legal proceedings, claims and assessments arising in the ordinary course of business. The Company records legal costs associated with loss contingencies as incurred and accrues for all probable and estimable settlements. Arctic Vision License Agreement On August 10, 2020, the Company entered into the Arctic Vision License Agreement pursuant to which Arctic Vision may develop and commercialize MicroPine for the treatment of progressive myopia and MicroLine for the treatment of presbyopia in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea. Under the terms of the Arctic Vision License Agreement, the Company received a non-refundable, upfront payment of $4.0 million, before any payments to Senju Pharmaceutical Co., Ltd. ("Senju"), due under the Exclusive License Agreement between the Company and Senju, as amended on April 8, 2020 and a Letter Agreement dated August 10, 2020 (the “Senju License Agreement”). The Company had recorded the $4.0 million payment as a deferred license fee until the payment is earned. The Company considers payment earned once certain trial data has been fully submitted to Arctic Vision, permitting Arctic Vision to obtain regulatory approval with the National Medical Products Administration. The trial data for one of the two products (MicroPine) was fully submitted to Arctic Vision by March 31, 2021. Therefore, one half of the upfront payment, or $2.0 million, has been earned. As a result, the Company will recognize $2.0 million of deferred license fees and recognize $0.8 million of deferred license costs related to the Senju payment as of March 31, 2021. In addition, the Company may receive up to a total of $41.75 million in additional payments, based on various development and regulatory milestones, including the initiation of clinical research and approvals in Greater China and South Korea, and development costs. Arctic Vision also will purchase its supply of MicroPine and MicroLine from the Company or, for such products not supplied by the Company, pay the Company a mid-single digit percentage royalty on net sales of such products, subject to certain adjustments. No royalty payments were earned through March 31, 2021. The Company will pay a mid-double digit percentage of such payments, royalties, or net proceeds of such supply to Senju pursuant to the Senju License Agreement. See Note 8 – Related Party Transactions for additional details. Bausch License Agreement On October 9, 2020, the Company entered into the Bausch License Agreement pursuant to which Bausch Health may develop and commercialize the Bausch Licensed Product in the Licensed Territory. In connection with the Bausch License Agreement, Bausch Health paid the Company a non-refundable, upfront payment of $10.0 million. The Company has recorded this payment as a deferred license fee until the payment is earned. The Company will consider payment earned once certain trial data has been fully submitted to Bausch Health and certain administrative functions are transferred to Bausch Health, permitting Bausch Health to assume supervisory oversight of the ongoing MicroPine study (the CHAPERONE study). The upfront payment had not been earned as of March 31, 2021. Bausch Health could also pay the Company up to an aggregate of approximately $35.0 million in additional payments, depending on the achievement of certain regulatory and launch-based milestones. No milestone payments were earned through March 31, 2021. Under the terms of the Bausch License Agreement, on a country-to-country basis and Bausch Licensed Product-by- Bausch Licensed Product basis, Bausch Health will pay the Company royalties on a tiered basis (ranging from mid-single digit to mid-teen percentages) on gross profits from the sales of the Bausch Licensed Product in the Licensed Territory, subject to certain adjustments in the event of generic entry, negative gross profits or patent expiration, for a period of the later to occur of the 10th anniversary of the first commercial sale of a Bausch Licensed Product in such country in the Licensed Territory or the expiration of the last valid patent claim for a Bausch Licensed Product in such country in the Licensed Territory. No royalty payments were earned through March 31, 2021.

XML 27 R16.htm IDEA: XBRL DOCUMENT

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2021
Related Party Transactions
Related Party Transactions	Note 8 – Related Party Transactions Lease Agreements The Company’s Vice President of Research and Development and Manufacturing (“VP of R&D”) owns a company that entered into a lease agreement with the Company on September 15, 2016 to lease 953 square feet of space located in Reno, Nevada with respect to its research and development activities. The initial monthly base rent was $3,895 per month over the term of the lease and the security deposit was $3,895. On September 15, 2018, the Company amended the lease agreement to extend it until September 14, 2020 and increase the monthly base rent and security deposit to $4,012. On September 15, 2020, the Company amended the lease agreement to extend it until September 14, 2022 and increase the monthly base rent and security deposit to $5,404. The Company made $82,500 of leasehold improvements related to this lease which are included on the condensed balance sheet. The Company’s rent expense for this space is recorded in Research and Development on the condensed statement of operations and amounted to $17,020 and $12,036 for the three months ended March 31, 2021 and 2020, respectively. Senju License Agreement During 2015, the Company entered into an Exclusive License Agreement with Senju whereby the Company agreed to grant to Senju an exclusive, royalty-bearing license for its microdose product candidates for Asia to sublicense, develop, make, have made, manufacture, use, import, market, sell, and otherwise distribute the microdose product candidates. In consideration for the license, Senju agreed to pay to Eyenovia five percent (5%) royalties for the term of the license agreement. The agreement will continue in full force and effect, on a country-by-country basis, until the latest to occur of: (i) the tenth (10th) anniversary of the first commercial sale of a microdose product candidate in Asia; or (ii) the expiration of the licensed patents. As of the date of this filing, there had been no commercial sales of a microdose product candidate in Asia, such that no royalties had been earned. Senju is owned by the family of a former member of the Company’s Board of Directors and, together, they beneficially own greater than 5% of the Company’s common stock. On April 8, 2020, Eyenovia entered into an amendment (the "License Amendment") to the Exclusive License Agreement. Pursuant to the License Amendment, the Company can license to any third party the right to research, develop, commercialize, manufacture or use certain products identified below (the "Senju Licensed Products") previously licensed to Senju in China (including the People's Republic of China, Hong Kong, Macao, and Taiwan) and South Korea (the "Territory") if such a license is executed by the Company by April 8, 2021. The Senju Licensed Products are those using piezo-print technology in a microdose dispenser with (i) atropine sulfate as its sole active ingredient to treat myopia in humans and (ii) pilocarpine as its sole active ingredient to treat presbyopia in humans. Pursuant to the License Amendment, the Company must pay Senju (a) close to a mid-double digit percentage of revenue on any lump-sum payments the Company receives from the third party, revenue (net of costs) obtained by the Company from contract research and/or development of the Senju Licensed Product in the Territory, and revenue (net of costs) obtained by the Company from contract manufacture for the device of the Senju Licensed Product in the Territory, the aggregate of which must be at least a high seven figure dollar amount minimum payment to Senju; and (b) a lower-double digit percentage of any sales royalty revenue the Company receives from the third party. Since the Company executed a third-party license prior to April 8, 2021, the License Amendment will remain in effect for the duration of the license, subject to early termination. The Exclusive License Agreement was further amended in a Letter Agreement by and between the Company and Senju on August 10, 2020 (the “Letter Agreement”). Pursuant to the Letter Agreement, the Company will pay a mid-double digit percentage of certain payments, royalties, or net proceeds received from Arctic Vision in connection with the Arctic Vision License Agreement to Senju. See Note 7 – Commitments and Contingencies – Arctic Vision License Agreement for additional details.

XML 28 R17.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

3 Months Ended

Mar. 31, 2021

Stockholders' Equity

Stockholders' Equity

Note 9 – Stockholders’ Equity

Securities Purchase Agreement

Stock Options

In applying the Black-Scholes option pricing model to stock options granted, the Company used the following approximate assumptions:


	For the Three Months Ended
	March 31,
	2021		2020
Expected term (years)	5.85		5.85
Risk free interest rate	0.92	%	1.32	%
Expected volatility	96	%	101	%
Expected dividends	0.00	%	0.00	%

The weighted average estimated grant date fair value of the stock options granted for the three months ended March 31, 2021 and 2020 was approximately $3.82 and $4.13 per share, respectively.

A summary of the option activity during the three months ended March 31, 2021 is presented below:


				Weighted
		Weighted		Average
		Average		Remaining	Aggregate
	Number of	Exercise		Life	Intrinsic
	Options	Price		In Years	Value
Outstanding January 1, 2021	3,427,705	$	3.37
Granted	1,637		5.11
Outstanding March 31, 2021	3,429,342	$	3.37	7.7	$	7,126,014

Exercisable March 31, 2021	1,862,537	$	3.54	6.7	$	3,889,820

The following table presents information related to stock options as of March 31, 2021:


Options Outstanding			Options Exercisable
			Weighted
		Outstanding	Average	Exercisable
Exercise		Number of	Remaining Life	Number of
Price		Options	In Years	Options
$	1.24	260,000	4.0	260,000
$	1.95	673,544	6.3	673,544
$	2.72	764,419	—	—
$	2.74	6,000	7.8	4,333
$	2.89	263,500	—	—
$	3.11	659,849	8.4	369,646
$	3.43	58,920	—	—
$	3.48	45,000	—	—
$	3.71	43,000	—	—
$	4.00	2,000	7.6	1,556
$	4.68	25,000	8.8	9,029
$	5.10	6,000	7.4	5,000
$	5.11	1,637	—	—
$	5.19	16,500	7.4	13,750
$	5.25	26,668	5.5	26,668
$	5.77	50,000	—	—
$	6.20	300,387	7.3	283,298
$	6.30	60,000	7.3	53,333
$	8.72	166,918	7.0	162,380
		3,429,342	6.7	1,862,537

Warrants

A summary of the Warrant activity for the three months ended March 31, 2021 is presented below:


				Weighted
		Weighted		Average
		Average		Remaining	Aggregate
	Number of	Exercise		Life	Intrinsic
	Warrants	Price		In Years	Value
Outstanding January 1, 2021	2,011,313	$	2.43
Exercised	(644,992)		2.37
Outstanding March 31, 2021	1,366,321	$	2.51	4.0	$	3,530,228

Exercisable March 31, 2021	1,366,321	$	2.51	4.0	$	3,530,228

The following table presents information related to Warrants as of March 31, 2021:


Warrants Outstanding	Warrants Exercisable
		Weighted
	Outstanding	Average	Exercisable
Exercise	Number of	Remaining Life	Number of
Price	Warrants	In Years	Warrants
$2.4696	1,149,941	4.0	1,149,941
$2.7240	216,380	4.0	216,380
	1,366,321	4.0	1,366,321

Stock-Based Compensation Expense

XML 29 R18.htm IDEA: XBRL DOCUMENT

Employee Benefit Plans	3 Months Ended
Employee Benefit Plans	Mar. 31, 2021
Employee Benefit Plans
Employee Benefit Plans	Note 10 – Employee Benefit Plans 401(k) Plan In April 2019, the Company adopted the Eyenovia 401(k) Plan (the “Plan”), which went into effect in May 2019. All Company employees are able to participate in the Plan, subject to eligibility requirements as outlined in the Plan documents. Under the terms of the Plan, eligible employees are able to defer a percentage of their pay every pay period up to annual limitations set by Congress and the Internal Revenue Service under Section 401(k) of the Internal Revenue Code. For 2021, the Company’s Board of Directors has approved a matching contribution equal to 100% of elective deferrals up to 4% of eligible earnings with the matching contribution subject to certain vesting requirements as outlined in the Plan documents. During the three months ended March 31, 2021 and 2020, the Company recorded expense of $64,178 and $57,971 associated with its matching contributions, respectively.

XML 30 R19.htm IDEA: XBRL DOCUMENT

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2021
Subsequent Events
Subsequent Events	Note 11 – Subsequent Events Stock Warrant Exercises Subsequent to March 31, 2021, the Company issued an aggregate of 232,022 shares of common stock pursuant to the exercise of warrants for aggregate proceeds of $573,001 at an exercise prices of $2.4696. Loan and Security Agreement On May 7, 2021, the Company entered into a Loan and Security Agreement (the “Loan”) with Silicon Valley Bank (the “Lender”) for an aggregate principal amount of up to $25.0 million. The Loan bears interest at annual rate equal to the greater of (a) the sum of 1.25% plus the prime rate as reported in The Wall Street Journal and (b) 5.00%. The Loan matures on May 1, 2025. The initial tranche in the amount of $7.5 million was received by the Company on May 7, 2021. In connection with the Loan, the Company issued to the Lender warrants to purchase 91,884 shares of common stock at an exercise price per share equal to $4.76. The warrants are exercisable for a period of ten years from the date of issuance. At the Company’s option, Eyenovia has the ability to draw down the remaining $17.5 million in gross proceeds in two tranches over the next two years based upon the achievement of several milestones in accordance with the terms of the agreement.

XML 31 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2021

Summary of Significant Accounting Policies

Liquidity and Going Concern

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents in the financial statements.

Net Loss Per Common Share

The following securities are excluded from the calculation of weighted average diluted common shares because their inclusion would have been anti-dilutive:


	March 31,
	2021	2020
Options	3,429,342	2,262,438
Warrants	1,366,321	3,344,154
Restricted stock units	105,306	60,355
Total potentially dilutive shares	4,900,969	5,666,947

Revenue Recognition

Step 1: Identify the contract with the customer;

Step 2: Identify the performance obligations in the contract;

Step 3: Determine the transaction price;

Step 4: Allocate the transaction price to the performance obligations in the contract; and

Step 5: Recognize revenue when the company satisfies a performance obligation.

During 2020, the Company entered into a license agreement (the “Arctic Vision License Agreement”) with Arctic Vision (Hong Kong) Limited (“Arctic Vision”) and a license agreement (the “Bausch License Agreement”) with Bausch Health Companies, Inc. (“Bausch Health”). Each license has three revenue components: 1) an upfront license fee; 2) milestone payments and 3) royalty payments. See Note 7 – Commitments and Contingencies for additional details.

Deferred License Fee

Deferred License Costs

Recently Adopted Accounting Standards

Recently Issued Accounting Standards

- Definition

Disclosure of accounting policy for revenue from contract with customer.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 20
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 20
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 20
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045

+ Details

XML 32 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2021

Summary of Significant Accounting Policies

Schedule of anti-dilutive weighted average diluted common shares

The following securities are excluded from the calculation of weighted average diluted common shares because their inclusion would have been anti-dilutive:


	March 31,
	2021	2020
Options	3,429,342	2,262,438
Warrants	1,366,321	3,344,154
Restricted stock units	105,306	60,355
Total potentially dilutive shares	4,900,969	5,666,947

XML 33 R22.htm IDEA: XBRL DOCUMENT

Prepaid Expenses and Other Current Assets (Tables)

3 Months Ended

Mar. 31, 2021

Prepaid Expenses and Other Current Assets

Schedule of prepaid expenses and other current assets

As of March 31, 2021 and December 31, 2020, prepaid expenses and other current assets consisted of the following:


	March 31,			December 31,
	2021		2020
Payroll tax receivable	$	270,682	$	151,942
Prepaid insurance expenses		863,119		110,094
Prepaid general and administrative expenses		109,918		—
Prepaid licenses and subscriptions		—		57,051
Prepaid conference expenses		21,603		29,403
Prepaid board of directors expenses		69,353		68,250
Prepaid rent and security deposit		25,004		25,004
Other		50,250		11,734
Total prepaid expenses and other current assets	$	1,409,929	$	453,478

XML 34 R23.htm IDEA: XBRL DOCUMENT

Accrued Compensation (Tables)

3 Months Ended

Mar. 31, 2021

Accrued Compensation

Schedule of accrued compensation

As of March 31, 2021 and December 31, 2020, accrued compensation consisted of the following:


	March 31,		December 31,
	2021		2020
Accrued bonus expenses	$	284,698	$	938,873
Accrued payroll expenses		286,034		211,799
Total accrued compensation	$	570,732	$	1,150,672

XML 35 R24.htm IDEA: XBRL DOCUMENT

Accrued Expenses and Other Current Liabilities (Tables)

3 Months Ended

Mar. 31, 2021

Accrued Expenses and Other Current Liabilities

Schedule of accrued expenses and other current liabilities

As of March 31, 2021 and December 31, 2020, accrued expenses and other current liabilities consisted of the following:


	March 31,		December 31,
	2021		2020
Accrued research and development expenses	$	1,119,083	$	348,254
Accrued consulting and professional services		18,167		235,355
Credit card payable		34,523		50,002
Accrued franchise tax		13,100		32,480
Accrued licensing fees		—		804,447
Accrued interest		4,219		3,068
Accrued expense reimbursements		—		5,459
Other		—		1,627
Total accrued expenses and other current liabilities	$	1,189,092	$	1,480,692

XML 36 R25.htm IDEA: XBRL DOCUMENT

Notes Payable (Tables)

3 Months Ended

Mar. 31, 2021

Notes Payable

Schedule of notes payable

As of March 31, 2021 and December 31, 2020, notes payable consisted of the following:


	March 31,						December 31,
	2021						2020
			Non-						Non-
	Current		Current				Current		Current
	Portion		Portion		Total		Portion		Portion		Total
BankDirect Capital Finance loan	$	627,756	$	—	$	627,756	$	—	$	—	$	—
Paycheck Protection Program loan		156,062		307,291		463,353		97,539		365,814		463,353
Total	$	783,818	$	307,291	$	1,091,109	$	97,539	$	365,814	$	463,353

XML 37 R26.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2021

Stockholders' Equity

Schedule of Black-Scholes option pricing model to stock options granted

In applying the Black-Scholes option pricing model to stock options granted, the Company used the following approximate assumptions:


	For the Three Months Ended
	March 31,
	2021		2020
Expected term (years)	5.85		5.85
Risk free interest rate	0.92	%	1.32	%
Expected volatility	96	%	101	%
Expected dividends	0.00	%	0.00	%

Schedule of the stock option activity

A summary of the option activity during the three months ended March 31, 2021 is presented below:


				Weighted
		Weighted		Average
		Average		Remaining	Aggregate
	Number of	Exercise		Life	Intrinsic
	Options	Price		In Years	Value
Outstanding January 1, 2021	3,427,705	$	3.37
Granted	1,637		5.11
Outstanding March 31, 2021	3,429,342	$	3.37	7.7	$	7,126,014

Exercisable March 31, 2021	1,862,537	$	3.54	6.7	$	3,889,820

Schedule of information related to stock options

The following table presents information related to stock options as of March 31, 2021:


Options Outstanding			Options Exercisable
			Weighted
		Outstanding	Average	Exercisable
Exercise		Number of	Remaining Life	Number of
Price		Options	In Years	Options
$	1.24	260,000	4.0	260,000
$	1.95	673,544	6.3	673,544
$	2.72	764,419	—	—
$	2.74	6,000	7.8	4,333
$	2.89	263,500	—	—
$	3.11	659,849	8.4	369,646
$	3.43	58,920	—	—
$	3.48	45,000	—	—
$	3.71	43,000	—	—
$	4.00	2,000	7.6	1,556
$	4.68	25,000	8.8	9,029
$	5.10	6,000	7.4	5,000
$	5.11	1,637	—	—
$	5.19	16,500	7.4	13,750
$	5.25	26,668	5.5	26,668
$	5.77	50,000	—	—
$	6.20	300,387	7.3	283,298
$	6.30	60,000	7.3	53,333
$	8.72	166,918	7.0	162,380
		3,429,342	6.7	1,862,537

Summary of the Warrant activity and related information

A summary of the Warrant activity for the three months ended March 31, 2021 is presented below:


				Weighted
		Weighted		Average
		Average		Remaining	Aggregate
	Number of	Exercise		Life	Intrinsic
	Warrants	Price		In Years	Value
Outstanding January 1, 2021	2,011,313	$	2.43
Exercised	(644,992)		2.37
Outstanding March 31, 2021	1,366,321	$	2.51	4.0	$	3,530,228

Exercisable March 31, 2021	1,366,321	$	2.51	4.0	$	3,530,228

The following table presents information related to Warrants as of March 31, 2021:


Warrants Outstanding	Warrants Exercisable
		Weighted
	Outstanding	Average	Exercisable
Exercise	Number of	Remaining Life	Number of
Price	Warrants	In Years	Warrants
$2.4696	1,149,941	4.0	1,149,941
$2.7240	216,380	4.0	216,380
	1,366,321	4.0	1,366,321

XML 38 R27.htm IDEA: XBRL DOCUMENT

Business Organization, Nature of Operations and Basis of Presentation (Details)	3 Months Ended
	Mar. 31, 2021
Business Organization, Nature of Operations and Basis of Presentation
Percentage Of Success Rate Of Optejet	90.00%
Percentage of Successful Rate of Traditional Eye Drops	50.00%

XML 39 R28.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Anti-dilutive weighted average diluted common shares (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Total potentially dilutive shares	4,900,969	5,666,947
Restricted stock units
Total potentially dilutive shares	105,306	60,355
Options
Total potentially dilutive shares	3,429,342	2,262,438
Warrants
Total potentially dilutive shares	1,366,321	3,344,154

XML 40 R29.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)			3 Months Ended
	Oct. 09, 2020	Aug. 10, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Cash and cash equivalents			$ 24,907,048		$ 28,371,828
Accumulated deficit			(82,792,586)		(77,440,919)
Net loss			(5,351,667)	$ (5,450,910)
Cash used in operations			(4,573,846)	$ (5,917,927)
Cash, Uninsured Amount			24,657,048		$ 28,121,828
Revenue			$ 2,000,000
Bausch License Agreement
Upfront payment received	$ 10,000,000
Maximum additional payments receivable	$ 35,000,000
Arctic Vision License Agreement
Upfront payment received		$ 4,000,000
Maximum additional payments receivable		$ 41,750,000

XML 41 R30.htm IDEA: XBRL DOCUMENT

Prepaid Expenses and Other Current Assets (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Prepaid Expenses and Other Current Assets
Payroll tax receivable	$ 270,682	$ 151,942
Prepaid insurance expenses	863,119	110,094
Prepaid general and administrative expenses	109,918	0
Prepaid licenses and subscriptions	0	57,051
Prepaid conference expenses	21,603	29,403
Prepaid board of director expenses	69,353	68,250
Prepaid rent and security deposit	25,004	25,004
Other	50,250	11,734
Total prepaid expenses and other current assets	$ 1,409,929	$ 453,478

XML 42 R31.htm IDEA: XBRL DOCUMENT

Accrued Compensation (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Accrued Compensation
Accrued bonus expenses	$ 284,698	$ 938,873
Accrued payroll expenses	286,034	211,799
Total accrued compensation	$ 570,732	$ 1,150,672

XML 43 R32.htm IDEA: XBRL DOCUMENT

Accrued Expenses and Other Current Liabilities (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Accrued Expenses and Other Current Liabilities
Accrued research and development expenses	$ 1,119,083	$ 348,254
Accrued consulting and professional services	18,167	235,355
Credit card payable	34,523	50,002
Accrued franchise tax	13,100	32,480
Accrued licensing fees	0	804,447
Accrued interest	4,219	3,068
Accrued expense reimbursements	0	5,459
Other	0	1,627
Total accrued expenses and other current liabilities	$ 1,189,092	$ 1,480,692

XML 44 R33.htm IDEA: XBRL DOCUMENT

Notes Payable - Schedule of notes payable (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current Portion	$ 783,818	$ 97,539
Non-Current Portion	307,291	365,814
Total	1,091,109	463,353
BankDirect Capital Finance loan
Current Portion	627,756	0
Non-Current Portion	0	0
Total	627,756	0
Paycheck Protection Program loan
Current Portion	156,062	97,539
Non-Current Portion	307,291	365,814
Total	$ 463,353	$ 463,353

XML 45 R34.htm IDEA: XBRL DOCUMENT

Notes Payable - Additional Information (Details) - USD ($)			3 Months Ended
	May 08, 2020	Feb. 24, 2020	Mar. 31, 2021	Mar. 31, 2020
Notes Payable
Repayments of loan			$ 77,604	$ 52,051
Interest expense			$ 1,151	$ 0
Notes payable
Notes Payable
Number of monthly payments		9 months
Debt Instrument, Periodic Payment		$ 79,343
Aggregate principal payments		$ 705,360
Interest rate (as a percent)		2.96%
Paycheck Protection Program loan
Notes Payable
Debt Instrument, Periodic Payment	$ 19,508
Interest rate (as a percent)	1.00%
Cash proceeds from loan	$ 463,353
Period for usage of loan proceeds	168 days
Interest rate on non forgiven amount	1.00%
Paycheck Protection Program loan \| Minimum [Member]
Notes Payable
Maturity term	2 years
Paycheck Protection Program loan \| Maximum [Member]
Notes Payable
Maturity term	5 years

XML 46 R35.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Additional Information (Details) - USD ($)			3 Months Ended
	Oct. 09, 2020	Aug. 10, 2020	Mar. 31, 2021
Arctic Vision License Agreement
Upfront payment received		$ 4,000,000
Deferred license fees			$ 2,000,000
Maximum additional payments receivable		41,750,000
Royalty payments earned			0
Bausch License Agreement
Upfront payment received	$ 10,000,000
Maximum additional payments receivable	$ 35,000,000
Royalty payments earned			0
Milestone payments earned			0
Senju License Agreement [Member]
Deferred license fees		$ 4,000,000
Deferred license cost			$ 800,000

XML 47 R36.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details)			1 Months Ended	3 Months Ended		12 Months Ended
Related Party Transactions (Details)	Sep. 15, 2020 USD ($)	Sep. 15, 2018 USD ($)	Sep. 15, 2016 USD ($) ft²	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2015	Dec. 31, 2020 USD ($)
Security Deposit				$ 119,035			$ 119,035
License Agreement
Minority Interest Ownership Percentage In Company						5.00%
Vice President of Research and Development
Net Rentable Area \| ft²			953
Lease, Monthly Base Rent	$ 5,404	$ 4,012	$ 3,895
Operating Leases, Rent Expense				17,020	$ 12,036
Security Deposit	$ 5,404	$ 4,012	$ 3,895
Leasehold Improvements, Gross				$ 82,500
Senju Pharmaceutical Co [Member]
Royalty Percentage						5.00%

XML 48 R37.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Black Scholes option (Details)	3 Months Ended
Stockholders' Equity - Black Scholes option (Details)	Mar. 31, 2021	Mar. 31, 2020
Stockholders' Equity
Expected term (years)	5 years 10 months 6 days	5 years 10 months 6 days
Risk free interest rate	0.92%	1.32%
Expected volatility	96.00%	101.00%
Expected dividends	0.00%	0.00%

XML 49 R38.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Summary of option activity (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Weighted Average Exercise Price, Granted \| $ / Shares	$ 3.82	$ 4.13
Stock Options [Member]
Number of Options Outstanding \| Shares	3,427,705
Number of Options Granted \| Shares	1,637
Number of Options Outstanding \| Shares	3,429,342
Number of Options Exercisable \| Shares	1,862,537
Weighted Average Exercise Price, Outstanding \| $ / Shares	$ 3.37
Weighted Average Exercise Price, Granted \| $ / Shares	5.11
Weighted Average Exercise Price, Outstanding \| $ / Shares	3.37
Weighted Average Exercise Price, Exercisable \| $ / Shares	$ 3.54
Weighted Average Remaining Life In Years, Outstanding	7 years 8 months 12 days
Weighted Average Remaining Life In Years, Exercisable	6 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding \| $	$ 7,126,014
Aggregate Intrinsic Value, Exercisable	$ 3,889,820

XML 50 R39.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Additional information related to Warrants (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Class of Warrant or Right [Line Items]
Outstanding Number of Warrants	1,366,321		2,011,313
Weighted Average Remaining Life, Exercisable	4 years
Exercisable Number of Warrants	1,366,321
Number of warrants exercised	(644,992)
Proceeds from exercise of warrants	$ 1,530,990	$ 0
Warrants at exercise price of $2.4696
Class of Warrant or Right [Line Items]
Exercise Price of Warrants Outstanding	$ 2.4696
Outstanding Number of Warrants	1,149,941
Weighted Average Remaining Life, Exercisable	4 years
Exercisable Number of Warrants	1,149,941
Warrants at exercise price of $2.7240
Class of Warrant or Right [Line Items]
Exercise Price of Warrants Outstanding	$ 2.7240
Outstanding Number of Warrants	216,380
Weighted Average Remaining Life, Exercisable	4 years
Exercisable Number of Warrants	216,380

XML 51 R40.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Warrants Activity (Details)	3 Months Ended
Stockholders' Equity - Warrants Activity (Details)	Mar. 31, 2021 USD ($) $ / shares shares
Stockholders' Equity
Outstanding at beginning balance \| shares	2,011,313
Exercised \| shares	(644,992)
Outstanding at ending balance \| shares	1,366,321
Exercisable Number of warrants \| shares	1,366,321
Outstanding at beginning balance \| $ / shares	$ 2.43
Exercised \| $ / shares	2.37
Outstanding at ending balance \| $ / shares	2.51
Exercisable \| $ / shares	$ 2.51
Weighted Average Remaining Life, Outstanding	4 years
Weighted Average Remaining Life, Exercisable	4 years
Aggregate Intrinsic Value, Outstanding \| $	$ 3,530,228
Aggregate Intrinsic Value, Exercisable \| $	$ 3,530,228

XML 52 R41.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Summary of information related to stock options (Details)	3 Months Ended
	Mar. 31, 2021 $ / shares shares
Options Outstanding, Outstanding Number of Options	3,429,342
Options Exercisable, Weighted Average Remaining Life In Years	6 years 8 months 12 days
Options Exercisable, Exercisable Number of Options	1,862,537
Exercise Price 1.24 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 1.24
Options Outstanding, Outstanding Number of Options	260,000
Options Exercisable, Weighted Average Remaining Life In Years	4 years
Options Exercisable, Exercisable Number of Options	260,000
Exercise Price 1.95 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 1.95
Options Outstanding, Outstanding Number of Options	673,544
Options Exercisable, Weighted Average Remaining Life In Years	6 years 3 months 18 days
Options Exercisable, Exercisable Number of Options	673,544
Exercise Price 2.72 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 2.72
Options Outstanding, Outstanding Number of Options	764,419
Options Exercisable, Weighted Average Remaining Life In Years	0 years
Options Exercisable, Exercisable Number of Options	0
Exercise Price 2.74 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 2.74
Options Outstanding, Outstanding Number of Options	6,000
Options Exercisable, Weighted Average Remaining Life In Years	7 years 9 months 18 days
Options Exercisable, Exercisable Number of Options	4,333
Exercise Price 2.89 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 2.89
Options Outstanding, Outstanding Number of Options	263,500
Options Exercisable, Weighted Average Remaining Life In Years	0 years
Options Exercisable, Exercisable Number of Options	0
Exercise Price 3.11 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 3.11
Options Outstanding, Outstanding Number of Options	659,849
Options Exercisable, Weighted Average Remaining Life In Years	8 years 4 months 24 days
Options Exercisable, Exercisable Number of Options	369,646
Exercise price 3.43 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 3.43
Options Outstanding, Outstanding Number of Options	58,920
Options Exercisable, Weighted Average Remaining Life In Years	0 years
Options Exercisable, Exercisable Number of Options	0
Exercise price 3.48 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 3.48
Options Outstanding, Outstanding Number of Options	45,000
Options Exercisable, Weighted Average Remaining Life In Years	0 years
Options Exercisable, Exercisable Number of Options	0
Exercise price 3.71 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 3.71
Options Outstanding, Outstanding Number of Options	43,000
Options Exercisable, Weighted Average Remaining Life In Years	0 years
Options Exercisable, Exercisable Number of Options	0
Exercise Price 4.00 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 4.00
Options Outstanding, Outstanding Number of Options	2,000
Options Exercisable, Weighted Average Remaining Life In Years	7 years 7 months 6 days
Options Exercisable, Exercisable Number of Options	1,556
Exercise price 4.68 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 4.68
Options Outstanding, Outstanding Number of Options	25,000
Options Exercisable, Weighted Average Remaining Life In Years	8 years 9 months 18 days
Options Exercisable, Exercisable Number of Options	9,029
Exercise Price 5.10 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 5.10
Options Outstanding, Outstanding Number of Options	6,000
Options Exercisable, Weighted Average Remaining Life In Years	7 years 4 months 24 days
Options Exercisable, Exercisable Number of Options	5,000
Exercise Price 5.11 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 5.11
Options Outstanding, Outstanding Number of Options	1,637
Options Exercisable, Weighted Average Remaining Life In Years	0 years
Options Exercisable, Exercisable Number of Options	0
Exercise Price 5.19 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 5.19
Options Outstanding, Outstanding Number of Options	16,500
Options Exercisable, Weighted Average Remaining Life In Years	7 years 4 months 24 days
Options Exercisable, Exercisable Number of Options	13,750
Exercise Price 5.25 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 5.25
Options Outstanding, Outstanding Number of Options	26,668
Options Exercisable, Weighted Average Remaining Life In Years	5 years 6 months
Options Exercisable, Exercisable Number of Options	26,668
Exercise Price 5.77 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 5.77
Options Outstanding, Outstanding Number of Options	50,000
Options Exercisable, Weighted Average Remaining Life In Years	0 years
Options Exercisable, Exercisable Number of Options	0
Exercise Price 6.20 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 6.20
Options Outstanding, Outstanding Number of Options	300,387
Options Exercisable, Weighted Average Remaining Life In Years	7 years 3 months 18 days
Options Exercisable, Exercisable Number of Options	283,298
Exercise Price 6.30 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 6.30
Options Outstanding, Outstanding Number of Options	60,000
Options Exercisable, Weighted Average Remaining Life In Years	7 years 3 months 18 days
Options Exercisable, Exercisable Number of Options	53,333
Exercise Price 8.72 [Member]
Options Outstanding, Outstanding Exercise Price \| $ / shares	$ 8.72
Options Outstanding, Outstanding Number of Options	166,918
Options Exercisable, Weighted Average Remaining Life In Years	7 years
Options Exercisable, Exercisable Number of Options	162,380

XML 53 R42.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Additional Information (Details) - USD ($)		3 Months Ended
	Mar. 24, 2020	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Common stock, shares authorized		90,000,000		90,000,000
Common Stock, Par or Stated Value Per Share		$ 0.0001		$ 0.0001
Preferred Stock, Shares Authorized		6,000,000		6,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.0001		$ 0.0001
Stock-based compensation		$ 656,913	$ 583,865
Aggregate number of shares issued including over-allotment option (in shares)	2,675,293
Net Proceeds From Issuance Of Common Stock	$ 5,300,000
Share-based Compensation		656,913	$ 583,865
Unrecognized stock - based compensation expense		$ 3,069,508
Weighted average period of recognition		1 year 9 months 18 days
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price		$ 3.82	$ 4.13
Proceeds from exercise of stock warrants		$ 1,530,990	$ 0
Directors And Executive Officers [Member]
Units issued price per unit	$ 2.42625
Research and Development Expense [Member]
Stock-based compensation		329,713	307,409
General and Administrative Expense [Member]
Stock-based compensation		327,200	276,456
Class A Warrants [Member]
Aggregate number of shares issued including over-allotment option (in shares)	1,337,659
Shares Issued, Price Per Share	$ 2.058
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.27
Class B Warrants [Member ]
Aggregate number of shares issued including over-allotment option (in shares)	2,006,495
Shares Issued, Price Per Share	$ 2.4696
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.724
Common Stock
Stock-based compensation		$ 0	$ 0
IPO [Member]
Aggregate number of shares issued including over-allotment option (in shares)	6,000,000
Units issued price per unit	$ 2.21425
IPO [Member] \| Class A Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.5
Warrant to purchase common stock in period	1 year
IPO [Member] \| Class B Warrants [Member ]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.75
Warrant to purchase common stock in period	5 years
Warrants at exercise price of $2.4696
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 2.4696

XML 54 R43.htm IDEA: XBRL DOCUMENT

Employee Benefit Plans (Details) - USD ($)	3 Months Ended
Employee Benefit Plans (Details) - USD ($)	Mar. 31, 2021	Mar. 31, 2020
Employee Benefit Plans
Defined Contribution Plan, Employer Matching Contribution, Percent of Match	100.00%
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage	4.00%
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount	$ 64,178	$ 57,971

XML 55 R44.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details)		1 Months Ended	3 Months Ended
Subsequent Events (Details)	May 07, 2021 USD ($) item $ / shares shares	May 31, 2021 USD ($) $ / shares shares	Mar. 31, 2021 USD ($)	Mar. 31, 2020 USD ($)
Proceeds from exercise of stock warrants			$ 1,530,990	$ 0
Subsequent Event [Member]
Warrants for purchase of common stock \| shares		232,022
Proceeds from exercise of stock warrants		$ 573,001
Exercise price of warrants \| $ / shares		$ 2.4696
Silicon Valley Bank [Member] \| Subsequent Event [Member]
Warrants for purchase of common stock \| shares	91,884
Exercise price of warrants \| $ / shares	$ 4.76
Debt Instrument, Face Amount	$ 25,000,000
Interest rate (as a percent)	5.00%
Loan received	$ 7,500,000
Maturity term	10 years
Remaining borrowing amount	$ 17,500,000
Number of tranches \| item	2
Silicon Valley Bank [Member] \| Subsequent Event [Member] \| Prime Rate [Member]
Variable Annual rate	1.25%

EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
,"1)W'MPYWT4K]]3\>9_A:-?4$L#!!0 ( !*!KE*7BKL
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
&PO=V]R:W-H M965T&UL4$L! M A0#% @ $H&N4KE18P&] P +@T !D ("!O]P 'AL M+W=O&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E M;'-02P$"% ,4 " 2@:Y2+M+XP*X! #*&@ $P @ 'K LZ@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 - T ",. #*[ ! end XML 57 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 131 295 1 true 53 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.eyenoviabio.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Condensed Balance Sheets Sheet http://www.eyenoviabio.com/role/StatementCondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.eyenoviabio.com/role/StatementCondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Condensed Statements of Operations Sheet http://www.eyenoviabio.com/role/StatementCondensedStatementsOfOperations Condensed Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Condensed Statements of Changes in Stockholders' Equity Sheet http://www.eyenoviabio.com/role/StatementCondensedStatementsOfChangesInStockholdersEquity Condensed Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00305 - Statement - Condensed Statements of Changes in Stockholders' Equity (Parenthetical) Sheet http://www.eyenoviabio.com/role/StatementCondensedStatementsOfChangesInStockholdersEquityParenthetical Condensed Statements of Changes in Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - Condensed Statements of Cash Flows Sheet http://www.eyenoviabio.com/role/StatementCondensedStatementsOfCashFlows Condensed Statements of Cash Flows Statements 7 false false R8.htm 00405 - Statement - Condensed Statements of Cash Flows (Parenthetical) Sheet http://www.eyenoviabio.com/role/StatementCondensedStatementsOfCashFlowsParenthetical Condensed Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 10101 - Disclosure - Business Organization, Nature of Operations and Basis of Presentation Sheet http://www.eyenoviabio.com/role/DisclosureBusinessOrganizationNatureOfOperationsAndBasisOfPresentation Business Organization, Nature of Operations and Basis of Presentation Notes 9 false false R10.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.eyenoviabio.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 10301 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.eyenoviabio.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 11 false false R12.htm 10401 - Disclosure - Accrued Compensation Sheet http://www.eyenoviabio.com/role/DisclosureAccruedCompensation Accrued Compensation Notes 12 false false R13.htm 10501 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.eyenoviabio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 13 false false R14.htm 10601 - Disclosure - Notes Payable Notes http://www.eyenoviabio.com/role/DisclosureNotesPayable Notes Payable Notes 14 false false R15.htm 10701 - Disclosure - Commitments and Contingencies Sheet http://www.eyenoviabio.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 15 false false R16.htm 10801 - Disclosure - Related Party Transactions Sheet http://www.eyenoviabio.com/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 16 false false R17.htm 10901 - Disclosure - Stockholders' Equity Sheet http://www.eyenoviabio.com/role/DisclosureStockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 11001 - Disclosure - Employee Benefit Plans Sheet http://www.eyenoviabio.com/role/DisclosureEmployeeBenefitPlans Employee Benefit Plans Notes 18 false false R19.htm 11101 - Disclosure - Subsequent Events Sheet http://www.eyenoviabio.com/role/DisclosureSubsequentEvents Subsequent Events Notes 19 false false R20.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.eyenoviabio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.eyenoviabio.com/role/DisclosureSummaryOfSignificantAccountingPolicies 20 false false R21.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.eyenoviabio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.eyenoviabio.com/role/DisclosureSummaryOfSignificantAccountingPolicies 21 false false R22.htm 30303 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.eyenoviabio.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.eyenoviabio.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets 22 false false R23.htm 30403 - Disclosure - Accrued Compensation (Tables) Sheet http://www.eyenoviabio.com/role/DisclosureAccruedCompensationTables Accrued Compensation (Tables) Tables http://www.eyenoviabio.com/role/DisclosureAccruedCompensation 23 false false R24.htm 30503 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.eyenoviabio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.eyenoviabio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities 24 false false R25.htm 30603 - Disclosure - Notes Payable (Tables) Notes http://www.eyenoviabio.com/role/DisclosureNotesPayableTables Notes Payable (Tables) Tables http://www.eyenoviabio.com/role/DisclosureNotesPayable 25 false false R26.htm 30903 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.eyenoviabio.com/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.eyenoviabio.com/role/DisclosureStockholdersEquity 26 false false R27.htm 40101 - Disclosure - Business Organization, Nature of Operations and Basis of Presentation (Details) Sheet http://www.eyenoviabio.com/role/DisclosureBusinessOrganizationNatureOfOperationsAndBasisOfPresentationDetails Business Organization, Nature of Operations and Basis of Presentation (Details) Details http://www.eyenoviabio.com/role/DisclosureBusinessOrganizationNatureOfOperationsAndBasisOfPresentation 27 false false R28.htm 40201 - Disclosure - Summary of Significant Accounting Policies - Anti-dilutive weighted average diluted common shares (Details) Sheet http://www.eyenoviabio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAntiDilutiveWeightedAverageDilutedCommonSharesDetails Summary of Significant Accounting Policies - Anti-dilutive weighted average diluted common shares (Details) Details 28 false false R29.htm 40202 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.eyenoviabio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 29 false false R30.htm 40301 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.eyenoviabio.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) Details http://www.eyenoviabio.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables 30 false false R31.htm 40401 - Disclosure - Accrued Compensation (Details) Sheet http://www.eyenoviabio.com/role/DisclosureAccruedCompensationDetails Accrued Compensation (Details) Details http://www.eyenoviabio.com/role/DisclosureAccruedCompensationTables 31 false false R32.htm 40501 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.eyenoviabio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities (Details) Details http://www.eyenoviabio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables 32 false false R33.htm 40601 - Disclosure - Notes Payable - Schedule of notes payable (Details) Notes http://www.eyenoviabio.com/role/DisclosureNotesPayableScheduleOfNotesPayableDetails Notes Payable - Schedule of notes payable (Details) Details 33 false false R34.htm 40602 - Disclosure - Notes Payable - Additional Information (Details) Notes http://www.eyenoviabio.com/role/DisclosureNotesPayableAdditionalInformationDetails Notes Payable - Additional Information (Details) Details 34 false false R35.htm 40701 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.eyenoviabio.com/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 35 false false R36.htm 40801 - Disclosure - Related Party Transactions (Details) Sheet http://www.eyenoviabio.com/role/DisclosureRelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.eyenoviabio.com/role/DisclosureRelatedPartyTransactions 36 false false R37.htm 40901 - Disclosure - Stockholders' Equity - Black Scholes option (Details) Sheet http://www.eyenoviabio.com/role/DisclosureStockholdersEquityBlackScholesOptionDetails Stockholders' Equity - Black Scholes option (Details) Details 37 false false R38.htm 40902 - Disclosure - Stockholders' Equity - Summary of option activity (Details) Sheet http://www.eyenoviabio.com/role/DisclosureStockholdersEquitySummaryOfOptionActivityDetails Stockholders' Equity - Summary of option activity (Details) Details 38 false false R39.htm 40903 - Disclosure - Stockholders' Equity - Additional information related to Warrants (Details) Sheet http://www.eyenoviabio.com/role/DisclosureStockholdersEquityAdditionalInformationRelatedToWarrantsDetails Stockholders' Equity - Additional information related to Warrants (Details) Details 39 false false R40.htm 40904 - Disclosure - Stockholders' Equity - Warrants Activity (Details) Sheet http://www.eyenoviabio.com/role/DisclosureStockholdersEquityWarrantsActivityDetails Stockholders' Equity - Warrants Activity (Details) Details 40 false false R41.htm 40905 - Disclosure - Stockholders' Equity - Summary of information related to stock options (Details) Sheet http://www.eyenoviabio.com/role/DisclosureStockholdersEquitySummaryOfInformationRelatedToStockOptionsDetails Stockholders' Equity - Summary of information related to stock options (Details) Details 41 false false R42.htm 40906 - Disclosure - Stockholders' Equity - Additional Information (Details) Sheet http://www.eyenoviabio.com/role/DisclosureStockholdersEquityAdditionalInformationDetails Stockholders' Equity - Additional Information (Details) Details 42 false false R43.htm 41001 - Disclosure - Employee Benefit Plans (Details) Sheet http://www.eyenoviabio.com/role/DisclosureEmployeeBenefitPlansDetails Employee Benefit Plans (Details) Details http://www.eyenoviabio.com/role/DisclosureEmployeeBenefitPlans 43 false false R44.htm 41101 - Disclosure - Subsequent Events (Details) Sheet http://www.eyenoviabio.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://www.eyenoviabio.com/role/DisclosureSubsequentEvents 44 false false All Reports Book All Reports eyen-20210331.xml eyen-20210331.xsd eyen-20210331_cal.xml eyen-20210331_def.xml eyen-20210331_lab.xml eyen-20210331_pre.xml http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 true true ZIP 61 0001104659-21-066855-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-21-066855-xbrl.zip M4$L#!!0 ( !*!KE(LK!Y-RLP +9[$ 1 97EE;BTR,#(Q,#,S,2YX M;6SL?5MSXS:V[O.9JOD//)YD5U(EJWG1U9WT*;4OLWVFN^VQG)Q=,0A+3 M%*D0I&W-P_GM9RV E$C=*5$216'/3F**)+"N'Q: Q85?_L_[P%%>J<]LS_WU M3*NJ9PIU3<^RW=ZO9R$[)\RT[;/_\^FO?_GE?Y^?_\_GAR^*Y9GA@+J!8OJ4 M!-12WNR@KSQYPR%QE:_4]VW'43[[MM6CBM*N:FI5K6JUAG)^'K7RF3!XRW,5 MWIQ>U<9W+J,6/?="J7_0:A]T5=>4YH7>NH &.E_%@^\OOJ, W2[[]:P?!,.+ M#Q_>WMZJ^'/5\WOPDFI\L%T6$->D9^+)"\=VOR]Y'&^_ %WQX^\SS[\9_&FM MW6Y_X'?'CT)#ECU^-MENXX.X&3]JT:GGK/>_U ]Q 7M5S53LWM&3+=@8> MZ8BZJG:DPZL)E7T[7FLB[$$_$+8!$]0H;C%[J$O?"' MHQMSF&!^,/LX_#B/7V;/$SD0HGWXGZ]?'LT^'9#S::[#P%_(0/L#W#T#HU&4 M7U!G%XRW\4"["M?A13 :TE_/F#T8.M@@_ZWOT^ZO9RB[\UA@U7=FG2D?1$-H MJ)X;T/= >:1F )[#[1+NF-'/MO7KV57H$[SW;#SKM6=D]OG)2UQ$$GM^#%^8 M;=G$'ST2A]YU'P//_-YYM]GXB=O[NZ]T\$(C1J ?\#X[&$57<&U;^$O7IK[" M&:0I@<1&=GG[C[-/*@BST=(;1ON7#Y/7)DTQVD/G'O\ /PD;OJ#O0\$ VD96KO\,@8-+;S#T M7+AD7,MH9\^7#F'L7\3W"?Q\),I>QM79)V3K8@Y;4N\S>O]<4L5_+IWF.^SY MK@N:-C34M+:FIN.G'FA ;)=:U\1W(;XJA[KCQ^8SE[?.Q=@?H"HU5*6A_?(A M_FV?JNQ8EHT00)Q[8ENW[B49V@%Q2J71I3P67;&:'FEV73B63KH+7:KGFGXX M74HO+;AF#>FDA7#2'$=2Z:-%\M$<1U*M+9WT<$ZJM?,<23/K4GIIP36[Z40& M?AYX+E^H*Y4R9_@J[81%:O#(@UFIP&./=*0&#SX*CM?DM>=H'.1+\C.#8I_X ME.\_(\\@%OX2_Y5UPJ#O^?9_J/6;:U&?LWTWQ/OW#G'9Y]'U._5-F]%[WS;I M W%[=+*0G[KW].8=B1WD+XYH V"^/':Z!:#A9K*JK=H"&(_66V[^%,+0^CZE MTM3F2T0:6\[&1EUI:O/D(0TM7T-[M-^EHULB%FEV^9K=C1=*@YLO$&EJ.9N:_2K'TOD"D::6 MKZE=.W*.,&5L29%(<\O9W.Q>/Y#6-E\BTMCR-;9ZM=F4MC97(-+4\C8U39.F M-E<@TM3R-;5:M=&2IC97(-+4\C4UH]J4J#9?(-+4\C:UFD2U^0*1II:[J1G2 MU.8*1)I:OJ:F5UMM:6IS!2)-+6]3:^K2U.8*I 2FMO C*)GO7:9\[SV4_Y!Y MVV7+VRZ-T]9[RJ$MC,#+787_YT&4Q&IG7O*>\YK(8C,Q/ M/DA^\W[+8W9R/S=_>7OEL5H9![N MWO)PRV,R,I]V3_FT93$9F1>[M[S8LIB,S&_=6WYK>4Q&YJGN*4^U1"8C\TWW MDV]:%I.1>:-[RQLMC\G(_,\]Y7_NH33Z%;S^"G)YI;?0L,_/HWVP6?K8:NXA='7S "7VMRA-@N4C2WUO!^OS05UV\]:/0VZ#]3!T[GO MP7)&3SX,-X0??CP9<'^'8>4>1BDNX;ON V64^&:_ T9$7ZGC#9&=XU#J$EZC MP30#L[L]^*!]KM5S4;76DJHNKJJUUG:J'H_%]<187)^-QL,71O\,@:KK5_C7 MTVA(T_""8UABK<2 M&$!ZY&_(D;_ (W\CCR!O?+I5_9GYP?/=FTM]UK>'$\U^ 69=1CL]G]+B*Q&8 MN$@Q$:EL/A<[U$Y]-^F.[Q#5I"?2XFK6BJW'NFK-TR/TZ M9"['@#Q(^IU^Y]4 K^>ASVLDB&D=4L$.(J4SG\TDP6"J9U M.>EZ2IF[';/JYVHS[]!#3N8*-YG;-CQ9<^%&:KX@FB_ VIZ:-!&YG5=L$U'7 M,Q$U)Q,91U5\,^CP$5;1#:FL 5,.>UG-M?:R\+&M;;8UAK7QW[BF.WQ[!7>[3<;2S_7:MNM<,B5G;V',]!+,]KL_,YX8@%W?WM\=B<:722)" M[3FBR#MVGBO-B=F-Q;E;G#"VQHG-3>VSM+6QK7V6QK9/7"N-W60SF^-5W^>2 MZB^CWQ]>@='J[_GN;;D3QD]%EEH*!XP?2_%4PBV7 M!0KOO!'?FIF_/5 6^+894(N'"+^Y=L >'G\[#H6G6)HH>"E/IZ-P\<'?K6O1 M=VH]>;>,A=1GPC=F$^@'0\<;47IT7T"NPV4BEWX1FR4TBP5;KQ+X2[>1NESA M$OA/3.$2^(L"_(L!G0DF<5+V$P-%JOXE(:1-(R_4Y?ZQ %Y=:R! M[=HPUO+*(^4SC;4X+:%Q+(@G)&H4!S4*%6A*U"@6:NS'.!9NZY1H"[>4VZ>8 M#OAD!\@03)OL5]L*P5S'>VY7_!,]SV=8D.*=FB$:[UVW:YLPKRJVWC#3;RYG MT;;;&JP55XVY3N\ZEF5C8\2Y)[9UZT9?9!9;O1EG>4MY/)VP3<[W#S'?+U2 M)C'A\)APA&N \// -P*N>MV<.>SQR4U"?@[OAG8 MYN\VBO2XZF_%>IW+7!3SK^:N?-ZOU=$($M76UO[>^I&Z?X3W?>(/B$EA>F02 MY]([#B-8_7WU$N9V:0-:?2T;F!1Q.^ ((+)N)S Y/DF^Z-I?*^MV#E\E' %6 M*9XG'R?7Y8Y?Z=,LG8C"YW[[6^YO>^5WM].?:DJU%Z108*3-8R\P5W03D.5/ M9FQOR])MX_%D\A$_#"CRB_X#?M$_/9Z(;_I7CB?BL2VC"B-I!>.+@W\:-2T2 M8SV1&'F(9..UE<\D!*&4;U5E&5^E6D]1G]MC7YA<2,WO7_/JN88G3:UV^>BQ M+37?0G7'FI]U,9-$I!C)N.$3ZJ2'7.#/R49E6=/2ES4M[C94 ME 05B?W.?[![_<38&*NC$UR_4]^T&83U,*0\]6$\.0[36\A@9':K.2S5UM0. MC.'&"_U2V\*$P1*8PJ( 60+!WH%@]TLT/O3*4'SZ39W4'516)MRQ-_ MEV?5'YS1@Q7\J*.Z"VC&^/7,;DHK')S1/846__O\'$ME*H\B>?K\7/P?';XU6Z-R'A^>_S M9J^HZPUL=U'#0A"L3WS*%K4\V\0O'Q(<+&98GY'90CX6-[) =_-(3C8"IO44 M#ATZ;5OP^[7#5Q.F[UC4ONC #0MOWCBDIT2V^D"[JQVV2QP&QC33R*3MR]#W M\4>;F<3Y-R7^M?"33-VX!FY@T?,WQ^!)^ M]XG#:\O^@XXR]9 $_(4MSG0X^5[MD7O471C@>&;9;MK^IX=B!5V-WQ%>JEC4 MM ?@!+^>W7Z[ ;G66_5ZO9VF94EG,X0)VWZ@0\\/X#XN F:THW\C/JQJ<;K? M:T#1'MS]N^^]!7U<:R1N-CT$?DB3_4$OA+24[3S4]W>\M=.3CGO\K!=S\ M%J?[?: ]7AC/#;Z103;?O?[W];>[WV\[%>7VVV4UV76ZT>DN'_O4<38QH1EU M)EN:Z06\SOD<,MNE+)N#3%MJJJ5)-S!.AC[-H\.(Y MF>U#])!J0S0M]]^U7<(Q[AY@\"+GK=L$[W=ZEQX+ERIN:#4[A MKYX$8)@K:EJ]46] ++Y^[_F2.R6C%>2J6U%*K4O/9:&#J-YQK7O?ZX(!\YI+ MC]1_M4W*YL',S%+""B)UHV[4ZTE*U^\X5Y+7%JO6TAK-O B.JHD^4'OP$OJ, MJX5M)=!ZK=Y.4S>WC\U)V9$Y_I&IK7::AYDWL X:O9M1I_(^U:",W207)J>9-N9>UY?%(:F9NI89-B M,]Y0NITOM=1:K3;EZZG6LW>^J?>LZ'9I(>M<',>HM?1Z+4W46KWF1VP&[]': M:LO8CMBY.QG1I@5^,IR%P!F3;C0,G(^OU5&):"9$>ZJNM]:D=0$!&5CX%\4? MJ-5YA=ELCZ8DG(4/(\F'#@95K:\K\&4D;,[) QT0&ZO@?K&[V29O][5_;T9Y MJDM)^?J4Y[CY?Z(B2"6U[%4&--.:X7*@/F_4 *GU-8BGUMKDK8UPV4B?!3RC MN1;AV\#=MQ U?-?%30D6+2SAY :+ %F?1[%Q/'GW(01RA-'$XO=\7HN4$'Q? M7VJWVS!_M(+-1:[:P>2:V&LY3+"TFH ,+&0,EA;/'6?!HV:LR<4V\+$Y*[G% M?3OG9&?1TYI=)BGGM=LNB6]%1;2V6[=4574\-$ZWG+'7]3VL5M>--3J]HEWJ M^_$J#,4%\[6F?AM^X[:,ZO,ZKDOA_T5TSZ%M.>7LWG-L<_0$Q']V%@+\ BOZ M+R?X:-FO_]4+/BJ)O__ZE__UO_!RJ+!@Y-!?SP8$]V#?NW[+9T"&C"]OE'? '8UDHD3 4+@U\\P.^FN3CPS ;5\2Q M>^[%'R$+[.Y(_!1= 4!]<]MBV(1RV%_3[P^]9$]L4M*D0*F "&>XD2LD]CD MF/+6M\V^,O0]S#Y2NIZO#,F()_-XW?'S)M^]=5K?V1*3XUJ3U,-=*EE%45( W^COI@"O$I/NOY%FB&,##U2$OIK@&: MH$/'45[2CQ-7H6(-#QBA+J?'%Y_#)_N%WUZI"^.QS2GS>BY(UJHJCW +BP(J M+65"OO%1B;ZH5_@G]4KBFWK&)43&!Y O0&Q'59=8D>1HR@?XHL/21>*+Q;[ M\[3'+O;O&TJE=T=:!UE(WY[Q;>$?8]=T/??=M&N54_6!5:U-0E ML<74WM-ZI.==A6,5!WH6#FQF.A[FN@(]\5[^ $<3;E]/Z!/[0M*"@DV'H?]] MQ9TSQ= J"K+'/>H*0(1_!13]JE84(D0(@IK($*7&;(9C*;2#OMWU',=[ V>\ MV R>"RHH#C_N"QM^7(,MA)*HK3?;"OH7FJK^&+4#MP,QL:&.,T28B;UL6=1/V,MWO*H.9 MO*G%;RXPG[3I1*846-FTI>I5M2&UM5A;:=EO+6ZMJK>DN/BUNWB3;CMB^=8\RA=J._E?VUB#= [3$5=W!1=":CJ M0<>OO"PCL>H@9MQELA6^OC,Q"4.K2+20:'$ M##XXM3Q6T:IT2)>^LT#,&28 M>' \D6'BD2AJU\!_=($@\QS;4B+F#HCM1VT N*,G75VZ>K&C..GJ^;BZ*J,S M,(;+R^OKFYO]8X$VNZ":CRVD*1.9&U$VQHOGABQ.DF2G@?0%TF_)MH.*+>R= M.=,/._";0^];YZ9*Q8B29J>&3-[Q<>E9T5NU2J/=DC I8;*\PCXFF#SXCKR$ MR3DPV39:E5;3.+W)1*G=-YXR#,G(]QRGS).&(NBQ^&->ME67(LAT9[ZQTWV1 M'4P%=JJZ,@UE>JM148V:Q#B)<1+C=H=QNXCC)<:MBW&:5FFVVZ<7KI_H//S) M"X@S]WO,$@YSQ=9QL0= '>Y;7HB?FVZQMUH@<1_3TE;>8?\AE5FFT;+>5"M- M0Y=0*:&R(-YU7 YT!+L $BKS@4JMHM752J.9#2RGIA;B$FM>C%]>HU[*]J)9 M(9?URWK@7^M7!\I2="91K.;6-7U*&+VBXK^W;ES=?S#- Y;(>D55Y'F"E+J0]$P4[8FWC*K1U7JS MI;9R9_$+OOX5Z.P[H\\$WUED4FU.M]9 NN'ONKB(RTY%)?UX1;]$0;])\:G? M@S55TW?$GO"H MR<4AV*O7U-J:[$W5*&-?R;L]" >=<7&Y^ZAK![/=J!S/5 M_M9E)#?>)QH'WO>G?DW-B>T-QMC,YR.V&PW5:*=)S3Z$;DGOVD% 6VWIAK8U MM7^&-KC>"%[[N\<9'+0HF$L60VLCYKA2NB.*_:9"59 M8UKI$P 3POKX'!D.?0^@&@(#9Z3\H->J;04(=+#L) J,N+@%$@Y"4U7*LV MIEMNSV^9U_0=TVUY0*CK!2#C5U[:%[A BXNK\V);?2(>&0%KQ.S;%,$=>N_: M@3B,8@J [B#!V()V^B10[ !+!HOX MCE-E32(\?MVC+C3C"".P!K;+#Y1&GLEYT\CP"ARA^#(8) MO((ON!1T27PA?6S:0F:XF -.6M=V@2HD@L6'NHC:SS9C(990OQT,'?XSB:LU M+Z00_-T5]9A1A6O2RR5O45";-2D0O4H 0H3=T,>#4L'0AB!R!]W4]\)>/ZHQ M#6$H>L^D$#3EI]4H(""+@KS9^+08_,G#IMZ@V0IVP,(AGGG/&>F&00@"2=AN M.='Y:9'@(\Y!:>@66([<=$*+ 3*! ^)ARB7W$AV,7HE>P2;(P M= M[N&@#5]X&18H5]X\_SLW#*%-;D?QW]RM08^@AS1RI F--!6_%74Q*1..!!,+ M?B7F"&V#F^DKL1T^9T$J6,H>P1H'"$]8JMSS4VRL8Z4L-,'?63=$1#&]P0#/ MB &U_T=()X(101J+SI*NB.U\+NV FGW7<[P>P(Z0!QC3=X#F!""RRIBS&+/X MEZRB9CRO#OSBQ8,)/]+!$S[#:8]LGYA<4/-N36@0.$?=OBC3+IX3T)!D)\D- MR%B<00Y*N^VF1U$&L287.PH*/9$F777LTH#- S(2QT),# 8>QYKNRX<*&!< M77%8B+1/OJ?Z& !$HD%Q0*% >^(<#+Y7$$$7,B,TAB-:;F7D5\;!B9CYJPTQ M= !H_B"&G'CRLLD9?;N8=R46/Q>1FN#F&PWN?<]$++F!<>D61AJTJ;ONAN>2 MK9P2UHWDC'"=[I/4>@%ET:%!D\7]_<]6=CX(S'QPSM]$]B>[)(VIHE'Q@0Q< M2$HDIVK9VO=&H-F5% MW;'!;+1;O,?:]5JU49/:VF.Y:576/]Z?N)L2B_9KW1),))B45=P23"28E%G< M$DSV*.YVU9#6+<&DM.*68+)'<3>J37EFE 23THI;@HF6GS1;+YXH0+WSSW7 XS)7$Y3:T:9V,[Z37E4#]TNO*XG5R';8H+B'7 M8XL8=K M(7%!1@P2&8X>&>1O"L_Q,>>K1ZHZ(V M= D^Q^ H$GPD^)0)? RU6=';93SBLX2.(L$G?YGN8(-<@L^:X%-K&!6C;DCP M.09'D>"3OTQWL.TLP6=-\&DW*W6C+;'G&/Q$8H^<=94)>XQ&O=+2:A)\CL%1 M)/A(\"D3^&PRZRK%WN:)YC"<4 VQ JFSV(.0#O==PF6 M8$C , 56&9(2*4KJ>SY\:AK[9)XPJ7A<>L7A-?,]G"G$M^*EK MFQ0N')N\V(X=0&,N"WU>)W_H.;8YJBI/T$BJ99M-_G05%RA5!L!$WQGA[P/J M!DPQ/9?9(#:WA_T.?=LU[2%Q>*]&_RAJ=8K1D--4$=,TP]!!Y/6X?\5'UN %_1JN_&C,J2^,J+$ MYV0,2!#"@XKG*M^\5SIX@9NQ@*M*:8WI*QDI+J> M2:G%N+0C"$%;8B&!+D!?A-<,P.=>@0O4*BK=C>H*O-E!G[>^K.@ X#051GK9 M>;A^5#IFH/R$EY,B%)XULQ$8P;3VR+8,D!<1RT MQXE=(C=:NU)76\H+!:6Y:'U >B?L@6*X[B>T^W1 ;/[$"W&X3U@A17M!&1I< MAKJ0(;]^"_+F7"@L!J%/P/0" _30J;ML%X8I4*!<==8)LVD(QO UV#U!D-\#DP>SM-;P5^ M,)T00R?H+\1X*Q!$0,^!5T''\CT@V?18(,:4 ;33(STZMO@*R!E1VU?"0&A+ M//P3!"L.ZO25.J-*RN?_&8+U=D?H>=?O0^H"F2GW1ZI"WP<:+' ['#^ 9KVF MO%'ZG:&\&/TSI *GNH RG'P^X+F1NR)QXC@8$!H=#!UO1"E_Q 2U0H]-X;W%'48NQN.=;!0RYJ!-+C,$),$T:$E?.'&:KRG][;]"U7P&!@X+B M(1E'WAAO@SX@2=+48],AD:U[+USG*6N!S(0/,@?E!5.FC3?*1E MHA/B\R%VW)*0?@K1 ,$2 !;9@8!AGR;!=U$DX*/)=RG7*<8$CL+L=]$&F%4W MB)#C<8"^^3ED-N>G8X&+0)CA"VT-R'>TY['SB%^]E RJRK_Z-@HHZ97>0 E7]"5X&@UIY]UFX[M)FNY 6G[T-_O*X[RS3_?MKS'Y M\XF:0_83.F&?INGML.>[[G/]N8GD:6,"OH"!WG4OP9SMX(:8'/1A!UYW;X -0;/9O&7CK33RVS/.M MUCJNSQTKCA3>I([ Q1=5;6QLC/1OH!IB/%,&'BZH?, \3[W M.P %((TXUR-ZY7O#!0BXEIVFR->1_/H\ZM<@8CGYXK6[84#_@& Q3WK;2^A- M]9HFT/:L2UQD@'&46J""WQA_$15]'X5;-S#>.[%@V4N M/R76I9#@9JLR!5V,Z?#9V)P)QA6,X7PI-/H59@W#2$(T*2&/2RB:..$4E4Y6 M?7%50LR-QQ/GBU))+].> TZD4AMEFJK^&+6#VVHB'*..$^U1(0;P:S:$B4-T M'6V\B6.9QQMOT788+J20(:,7\1\?14=*2ZV.^]KXP]5&NZH>]'20OD $7"4% M367=EEW7(M*]>*_4[X+I7O1MRZ)NPEXVVKKC;VKQFPO,)Y]=6%UJ:ZFV/O/ VQM'&&.WRQUA'GH>IJ(O+M2L U>#3S>.W MC,2J@YAQE\E6^*)/8EU,JTBTD&B1&UH4.$MC#7L_-N*@T>W$HS7<,5XN3T/ M/)91^,'A6D;A1Z*H78^K1Q=G9ZL?NSML/VH#P%U4Z>K2U7-U]=9ARV]+5U_D MZJJ,SD[D:^DHR54)R'OTT1#_%O8DD+Y ^BW9;ENQA;TS9]I!Z8&#IP7(P@-S M"@_H3;72:.WB9%$DQ(F"R+LHX+) BX)2YC4ZEJE7//"B;U M5.+T^1*.AT709,E&O?*)].!!^@F/,:V&4=&T7526E= CH:?P(CUXX'O"T*-I M:D5M9ZO46HKP]D3GK7'@VZ,N]8DS\63\:I0D"O:\ECHD+K;V2S9BG9*P#QY& MRT6<>:.1'\:^>1]XM'?%XT?'(^98DC\"*H MM&3C4_E$>O!H^H3'FD8[\XG)$GDD\I1$I >/?T\9>5H5O2X+BQ1L?KGS^%<< MHH-)&-2,#I*F0X_900G'H&*KNF2C4[&%O3._VF7EQ8,'YG)Y:-[R4+VBJMF^ M,I)P*>'RJ(1]G'!YZ-F$A,M\X+(4\XQ2NS$_M;2$0V 1E%;\@2Y;6=
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�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end